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CHAPTER I INTRODUCTION  
Haemorrhagic septicemia (HS) is reported endemic in tropical Asia and some regions of Africa, 
it is responsible for causing increased mortality in livestock (Bain et al., 1982). It has been 
declared that HS causes primary pasteurellosis which asserts high morbidity and mortality upto 
100% in the diseased animals in some endemic regions of Middle East, southern Europe, Asia 
and Africa (OIE, 2009). Cattle and buffaloes, which are used as a source of draught power to 
plough and to get milk in various parts of developing countries, are affected by the outbreaks 
of heamorrhagic septicaemia as detailed by Benkirane and De Alwis, (2002). The causative 
agent is P. multocida, which is classified on the basis of their antigenic ability into five 
serogroups  and are known as capsular types A, B, D, E and F  (Boyce and Adler, 2000 and 
Rimler, 1987) and serotypes 1-16 is based on the presence of lipopolysaccharide antigens. The 
capsular type of serogroup is usually related to the tendency of disease, with the HS strain 
belonging to serogroups B and E (Verma and Jaiswal, 1998). In the recent past (1987), African 
E:2 serotype and the Asian serotype B:2 (Carter & Heddleston system) were the cause of 
disease occurrence (De Alwis, 1987). Previously, the researchers separated a nontoxic 
polysaccharide capsular antigen, which was nonimmunogenic in rabbits but produced mouse 
protective antibodies in cattle (Penn and Nagy, 1976). Very less information is accessible about 
those antigens of P. multocida that have the potential to stimulate an immune response in cattle. 
In HS, capsular antigen, lipopolysaccharides protein complex, and the outer membrane 
proteins (OMPs), and together with iron-regulated outer proteins, are very important and 
valuable immunogens of the two serotypes B and E were reported by Carter and De Alwis, 
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(1989). Analogous to all Gramnegative bacteria, the envelope of cell of Pasteurella multocida 
has an inner membrane which is symmetrical and outer membrane which is non-symmetr ica l 
and is divided by the periplasmic space and peptidoglycan layer (StMichael et al., 2005). The 
outer membrane consists of an inner prominent phospholipid layer and an outer 
lipopolysaccharides leaflet (Corterton et al., 1974). It acts as a selective barrier and controls 
the flow of required nutrients and different waste materials into and out of the cell, and is also 
considered the interface involving the host and pathogen. There are two types of proteins in 
the outer membrane, i.e. peripheral lipoproteins and integral membrane proteins, together they 
account for about 2-3% of the overall encoded proteins (Lin et al., 2002 and Chung et al., 
2007). Integral outer membrane proteins usually have a structure which is β-barrel shaped and 
the lipoproteins are attached to the internal leaflet of the outer membrane (Ruiz et al., 2006 and 
Schulz, 2002).   
The outer membrane proteins have various essential roles for bacteria, they allow them 
to settle to unusual environmental conditions and host niches (Ruiz et al., 2006). These roles 
may be integrity, biogeneiss of the outer membrane, energy-dependent transport nonspecific 
porin activity (Lin et al., 2002). In P. multocida, some OMPs have significant roles in 
pathogenecity and have been used as potential immunogen for vaccine production as found by 
Dabo et al., (2007). Pasteurella multocida capsular strains type A and type F were compared 
for outer membrane protein profiles and also analyzed for sequence. On the basis of molecula r 
heterogeneity, the heat adaptable ompA and porin ompH were identified, which play vital roles 
in host pathogen connections (Davies et al., 2003).  
What causes carriers to become shedders is not predicted. A carrier animal may shed 
intermittently and repeatedly without contracting disease itself, or may develop fulminating 
HS after previous episodes of shedding without signs of HS. The disease outbreaks occur when 
carriers or diseased animals shed large numbers of organisms into the immediate environment 
of susceptible animals through nasal and oral excretions (De Alwis, 1999). Buffaloes are 
extensively considered more susceptible to HS to be having a shorter course of disease than in 
cattle (De Alwis, 1999).  
Although HS may be controlled through vaccination, most of the vaccine efficacy 
response was restricted to homologous species (Shah et al., 1997). Currently used vaccines of 
live attenuated strains of P. multocida are undefined and various outbreaks of pasteurellos is 
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have been attributed to the vaccine strains (Davis, 1987 and Muneer and Afzal, 1989). The 
majority of the large ruminants are vaccinated against HS by using an alum precipitated vaccine 
in Pakistan. Poor antigenicity and improper handling, storage of vaccine and use of 
immunosuperssing biological agents are incriminated to be the cause of failure of 
immunoprophylaxis in the vaccinated animals (Ajmal et al., 1987).  
Alum precipitated vaccine provides reliable immunity for only 3-4 months and 
anaphylactic shock reaction may also occur (De Alwis, 1999). Reports also indicated that the 
bacterin provided limited protection against heterologous serotypes and the vaccinated animals 
suffered from disease outbreaks (Rebers and Heddlest, 1977 and Davis, 1987).  
International organizations which have played a significant role in the control of HS 
are the Food and Agriculture Organization (FAO) of the United Nations, Australian Centre for 
International Agricultural Research (ACIAR) and the Office International des Epizooties 
(OlE). These organizations provided assistance includes encouragement and funding of 
research, keeping strandards of health regulation for international trades, developing of 
diagnostic techniques and vaccine production technologies, services of consultants, training 
opportunities and facilitating control of the disease through strengthening and establishment of 
national diagnostic and vaccine production laboratories in the countries where the disease 
occurrence is high.  
In 1978 the Food and Agriculture Organization and United Nations Development 
Program coordinated a survey on the impact of disease on production in the Azad State of 
Jammu and Kashmir, near the border of India and Pakistan. The survey was carried out as part 
of the National Program for Livestock and Dairy Development. It was declared, that nutritiona l 
disorders and parasitism were the greatest sources of loss in livestock. Of the bacterial diseases 
however, HS and black quarter made the most significant contribution to losses. Pakistan ranks 
HS as a disease of considerable economic importance, with 34.1% of all deaths in susceptible 
animals caused by HS (FAO, 1979). Cattle production in Pakistan is of 39.7 million heads, and 
the buffalo population is of 34.6 million heads. The annual economic losses due to the disease 
were estimated worth more than 2.17 billion in Punjab (Anonymous, 1996). As a result of an 
assessment it was estimated that the livestock sector contributed approximately 55.9 percent to 
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the agricultural value addition and it contributes 11.8 percent to national GDP during the year 
2013-14 (Economic survey of Pakistan, 2014).  
The anti-idiotype network hypothesis was proposed by Niels Jerne (Jerne, 1974). 
Further studies have elaborated that different antigenic determinants within variable domains 
of immunoglobulin, not only recognize but also obtain an immune response in the simila r 
individual (Jerne, 1974 and Bona, 1996) and these antigenic determinants are individua lly 
recognized as idiotypes. Many groups of researchers (Jerne, 1982, Bona, 1984 and Yang and 
Thanavalla, 1995) have intensively investigated the potential immune regulatory role of Ids – 
anti-Ids interaction.   
Anti-idiotypic antibodies were demonstrated in prion-biology, which was based on the 
recognition of a specific antigen combining site of an antibody, mimicking the structure of 
prion antigens. Anti-idiotype vaccine is useful to improve the conventional experimenta l 
vaccines, and it is especially recommended when the molecule is infectious, toxic or difficult 
to isolate and purify (Venturini et al., 2009).  
In spite of regular vaccination with conventional vaccines, haemorrhagic septicaemia 
remains to be a main dilemma. The young ones become more susceptible to HS when maternal 
immunity waves off and this is probably the most appropriate time for vaccination. The plan 
of this study was designed to assess the immunogenicity and effectiveness of an indigenous 
strain (local isolate) of P. multocida B:2 OMPs anti-idiotype vaccine in as long as safety against 
a homologous challenge for the prevention of HS in cattle under field conditions with fallowing 
objectives.  
1. Isolation of indigenous P. multocida from HS inflicted cases of cattle and buffaloes.   
2. To demonstrate biocharacterization of indigenous (local) P. multocida isolates.   
3. Purification of OMPs and preparation of subunit HS vaccine.  
4. Preparation and comparative evaluation of anti-idiotype and OMPs subunit HS 
vaccine in cattle and buffaloes.  
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CHAPTER II   REVIEW OF LITERATURE  
The concept of participatory disease surveillance (PDS) was presented by the Food and 
Agriculture Organization (FAO) in Pakistan conducted a research programme ’’Support for 
emergency prevention and control of main trans-boundary diseases in Pakistan’’ (Farooq et 
al., 2007). A total of 10% of the villages were randomly chosen from Khyber Pukhtunkhwa, 
Azad Jammu and Kashmir, Northern Areas, Baluchistan and Punjab. The data obtained by all 
PDS teams were analyzed using parameter like geographical distribution for the prevalence 
and importance of haemorrhagic septicaemia during the years 2000-2005. The reports were 
collected for getting the higher and lower risk areas of disease incidence. The prevalence 
percentage and importance percentage of HS in various districts of Punjab were recorded as 
the maximum prevalence of HS 49% in Khanewal districts while minimum 5.37% as well as 
lowest importance percentage 8.00% in Attock. Whereas the highest importance percentage 
(75.6%) was estimated in Faisalabad.  
2.1. Immunogenicity of bacterin  
The bacterins mostly cause tissue reactions and show lower levels of immunity against 
heterologous serotype (Rebers and Heddleston, 1977). It was reported, that buffalo calves were 
vaccinated with HS experimental oil adjuvanted vaccine (EOAV) (Shah et al., 1997) was 
developed with Mercel 52 minerol oil together with Span 85 and Tween 85. The group of 
animals had high levels of IgG and IgM class immunoglobulins as measured to the other group 
of animal immunized with  plain bacterin and control, i.e unvaccinated group of animals. The 
protection was 100% in animals vaccinated with EOVA at 250 days post vaccination.  
Killed and live Pasteurella multocida strain AL18 (acapsular mutant) M1404 (wild 
type strain) in 0.05 ml through I/M was injected into mice at day 0, a IInd booster dose which 
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was similar to the initial, was given 14 days later and challenged 15 days past the second 
immunization by I/P inoculation of the wild type P. multocida M1404 (John and Adler, 2001). 
Regarding the protection levels, Fischer’s Exact test showed a value of P > 0.05 was non-
significant detected in mice vaccinated with heat killed vaccine while, significant protection 
(90%: P < 0.001) was detected when mice were immunized I/P with live ALI8.  
 2.2. Capsule    
The capsules of Pasteurella multocida types B and E are not well characterized. The 
capsular composition of type B indicated the presence of mannose, arabinose, and galactose 
(Muniandy et al., 1992). However, it is also found that the method of preparation used in that 
study would not detect any amino or other modified sugars. The genetic locus for type B 
capsule biosynthesis suggested the presence of N-acetyl mannosaminuronic acid rather than 
mannose (Boyce et al., 2000). The capsular substance production of Pasteurella multocida is 
influenced by sub-minimal inhibitory concentrations of antibiotics as determined by Boyce et 
al., (2000).  
2.2.1 Immunogenicity of outer membrane proteins   
The radio-immuno-precipitation and western blot analyzed the presence of P.  
multocida outer membrane immunogens from the immune sera of four groups of rabbit. It was 
perceived that rabbits presented a response of antibody nature to the 18 proteins present in the 
OMP of Pasteurella multocida and the main antibody actions were focused on the 27 KDa 
OMP, in addition the OMP of molecular weight of  37.5, 49.5 58.7, and 64.4 KDa.  However, 
western blot analysis confirmed that the 27, 37.5, 49.5, 58.7, and 64.4 KDa were the major 
polypeptide fractions of Pasteurella multocida found in the immune sera of rabbits group 1, 3 
and 4 (Lu et al., 1988).  
A method was demonstrated for the separation of the envelopes from Pasterella 
haemolytica and Pasteurella multocida. It was also examined that the immunogenic protein 
with the highest molecular mass was present in all strains of Pasteurella haemolytica and 
Pasturella multocida by the use of immunoblot technique (Knights et al., 1990).   
The monoclonal antibodies were prepared especially against the outer membrane protein with 
a molecular weight of 37.5 KDa. It was observed that the 37.5 KDa protein fractions was the 
standard to achieve protecting monoclonal antibodies (Lu et al., 1991). A study was conducted 
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regarding the outbreaks of animals suffered from HS; P. multocida was isolated, among 
them14 isolates were processed for protien profiling through electrophoresis and divided in 
two groups relating to their country origin. The findings indicated that, a major protein fraction 
had a molecular weight of 32 KDa was related to North Amercian and Asian Origin (Carter B 
type). However, the protein fraction with a molecular weight of 37 KDa was related to African 
Origin (Carter E type). The serotype B and E strains presented the similar major bands 47,  45  
and 27 KDa and some minor  bands 37 and 32 KDa were detected  by Johnson et al., (1991).  
Using SDS-PAGE the outer membrane proteins from Pasteurella multocida B:2 
serotype were characterized and analyzed by Pati et al., (1996) and showed main protein bands 
having molecular weight reaching from 25 to 88 KDa. Through, immunoblotting techniques, 
the different protein band of molecular mass 44, 37 and 30 KDa were detected to be 
immunogenic. In an other study, P. multocida cultivated in medium enriched with iron, and a 
medium depleted with iron, or in vivo was compared and revealed that many OMPs had high-
molecular-weight were controlled by the different levels of iron and are identified as iron-
regulated outer membrane proteins (IROMPs). It was also established that IROMPs take part 
in cross-protective immunity as detailed by Srivastava, (1998).  
Five isolates of P. multocida serotype (A: 3) seven isolates and serotype (B: 2) were 
studied (Opacka and Kedrak, 2002) and accompanied by reference strain which was cultured 
on brain heart infusion medium, and the before mentioned medium accompanied with 2, 2-
dipyridyl. Extraction of the OMPs from bacterial cells was done by 1% Sarkosyl. SDS-PAGE 
was done on the OMPs detected and it was declared that strains harvested on medium includ ing 
iron chelator created additional iron regulated outer membrane protein (IROMPS).  
An experiment was preceded for extraction of outer membrane through Sarkosyl 
technique against P. multocida B: 2 serotypes, were taken out from field outbreaks and vaccinal 
strain (P52), OMPs were analysed using the SDS-PAGE and immuno-blotting methods. The 
findings indicated (Tomer et al., 2002) that, bands in the profile of the vaccinal strain were 
about 20 polypeptides with molecular mass ranged from 16 to 90 KDa and three protein bands 
of molecular mass 31, 33 and 37 KDa were measured as major bands of OMPs. It was also 
detected a minor difference in profiling of P. multocida field isolates as well as vaccinal strain. 
The outer membrane protein of 33 KDa was only conveyed by vaccinal strain. An OMP of 39 
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KDa was detected in four field isolates, which was not seem in the left over profiles of the 
lasting two field isolates including vaccinal strain. Directing immunoblotting techniques, it was 
exposed that the protein band of 37 KDa was most immunogenic fraction in the profiles of all 
the isolates, along with the P-52 strain, which was considered highly antigenic for 
immunoprophylaxis.   
To evaluate the immunogenicity of Pasteurella multocida serotype B:2,5 OMPs 
antigen complexes, a study was conducted by the scientists. The electrophoretical separation 
of OMPs through SDS-PAGE exposed protein bands with molecular mass ranged from 22, 28, 
32, 36, 46, 50, 58, 64 and 84 KDa (Opacka and Kedrak, 2003). An OMP band with molecula r 
weight 32 KDa established the highest OD value. The additional protein band pattern about 
102 and 110 KDa were produced when the strain was harvested with iron chealate medium. 
While the 84 KDa fractions shown a better OD expression in contrast to iron enriched medium. 
Results for the recognition of antibodies specific to OMPs in the sera of calves vaccinated with 
antigen complexes of outer membrane protein, that was (IROMPs) exhibited, that the sera of 
both vaccinated calves, cover the immune response specific to the protein band pattern 
observed in the examined strain.   
A major immunodominant antigen 16 KDa OMP of P. multocida was recognized. In 
that study the workers did amplification, cloning and sequening of the gene Omp16, encoding 
a 16 KDa outer membrane protein. The explanations recorded the complete homology of 
sequencing involving the 16 KDa OMP gene of Pasteurella multocida T16 (somatic serotype 
3, 4) and P. multocida B:2 (capsular serotype) P52 and this gene was disseminated with various 
serotypes of Pasteurella multocida and considered to localize in a  Hind III fragment (6.0 kb) 
of the Pasteurella multocida genome as explained by Goswami et al,. (2004).  
The value of immunogens of Pasteurella multocida (6: B) outer membrane protein was 
checked in vaccinated Swiss albino mice (Basagoudanavar et al., 2006). The immune response 
to the vaccine was investigated by indirect ELISA. The result indicated that OMPs Montanide 
immunized mice exhibited a more quick antibodies response than its liposomal counterpart, 
but the titres were related at 21 days post vaccination. The mice immunized with OMPs 
Montanide, were capable to endure after infectious challenge of  bacterial protection, it showed 
100% protection till 75 days post booster vaccine. Based on these findings the OMPs were 
proved as an important determinant of immune protection.  
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Few of the OMPs band fractions may react only with antibodies from the serum of 
vaccinated animals. P. multocida was investigated for bioinformatics analysis, the genome 
sequence data indicated that a total of 129 proteins were secreted and which were present in 
the OMPs, or lipoproteins with a restriction of total 79 proteins in the outer membrane were 
observed (Al-Hasani et al., 2007). Some of the earlier reports specified the 37 and 39 KDa 
protein fractions as potential protecting antigens. A few OMPs were recognized as Pm1069 
and interrelated proteins, hemoglobin binding (HgbA), transferrin binding protein A (TbpA), 
while several other were recoganized as OmpH, OmpA, Oma87(Wheeler, 2009).  
  
2.3. Anti- idiotype vaccine development  
The immune network hypothesis was described for the first time in the literature where 
it was established that the idiotype network could control in immunoregulation detailed by 
Jerne, (1974). In the hypothesis the lymphocyte antigen receptors (i.e. immunoglobulin on B 
cell and T cell) are accomplished to express different antigenic determinants with in variable 
domains of the antibodies, which become potentially immunogenic. It is exposed that the 
cellular and humoral response of an individual can be provoked against antigen receptors which 
are processed by the lymphocytes of that similar individual and such antigenic determinants 
are jointly recognized as idiotype. The anti-Id antibodies, bearing the inner image of 
corresponding antigen, are able to induce immune response of the original antigen in the host 
not formerly exposed to it, as predicted by Nisonoff and Lamoyi, (1981) and Herlyn et al., 
(1996).  
 Rabbit  polyclonal  anti- idiotype  antibodies  against  Yersinia  pestis  
lipopolsaccharide were produced (Feodorova et al., 1999). It was observed that the 
antiidiotypes antibodies had all fundamental properties of Ab2β subtype. The experiment 
exhibited a prominent adjuvant activity of anti-idiotype antibodies lacking toxic effect 
characteristics of Y. pestis lipopolysaccharides together in vivo and in vitro. By combined 
immnization of murine BALB/c with anti-idiotypes antibodies added with the FI capsular 
antigen of Y. pestis, the mean specific antibody titre was increased to 16000. The mice were 
challanged with 50 lethal doses (LD50) of virulent strain Y. pestis 231 at 14 days of last 
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immunization, which led to important increase in antibody response. The peak level of 
protection amongst the mice was observed through a value (p < 0.01).  
A thermal dimorphic fungus, Paracoccidioides brasiliensis is the most prevalent 
infection and it has a major antigenic component of 43 KDa glycoprotein (gp43). All the 
patients’ sera showed the antobodies against gp43, spontaneous anti-idiotypes (Ab2) were 
investigated with elevated titres of anti gp43. It was estimated that common of patients 88% 
(n=8) with an acute form of para-coccidioidomycosis had high titres of Ab2 (Souza et al., 2000) 
and advised that titres of anti-Id antibodies were correlated with severe infection of para-
coccidioidomycosis in humans.  
In another study, the mice were vaccinated intraperitoneally with anti-hepatitis B virus 
(HBV) mouse monoclonal and anti-HBV goat polyclonal antibody in order to generate anti-
idiotype antibodies. The mouse monoclonal antibodies (6C9, 6H9) attained from the fusions 
with mouse myeloma cells, the immunoprotective properties and specificities were dected. 
BALB/c mice were vaccinated with different doses of anti-idiotypie antibodies and it was 
evident that anti-idiotype antibodies created hepatitis B surface antigen (HBsAg), as well as 
bovine serum albumin (BSA) specific immune response. It was seen from the data that, 
vaccination of the mice with (HBV) resulted in the development of HBsAg-specific antibody 
response. Equally of the ant idiotype monoclonal antibodies 6C9 and 6H9 showed equivalent 
results in mice (Yildirim et al,. 2004).  
A non-cross-reactive, with host polysialic acid and protective capsular epitopes of 
serogroup B meningococcal capsular polysaccharide (MenB CP) have been used to develop a 
exceedingly protective mAb (mAb Seam 3), which were rose against a chemically adapted 
structure of the MenB CP, i.e. substition with N-propionyl (N-Pr MenB CP). Using liabries of 
filamentous of phage, expressing the anti-idiotypic single-chain antibody fragments (scFvs) 
were established from spleen cells of mice, which were vaccinated with 50 μg of Seam 3 mAb 
through subcutaneous routes. Two Seam 3-specific scFvs compared with N-Pr MenB CP for 
binding to Ab Seam 3 or rabbit antibodies present in typing sera. Furthermore, in the mice and 
rabbits due to the scFvs there was creation of antibodies reacting with both N-Pr MenB CP and 
whole cells of meningococci. These scFv-presented immune responses were accessible to 
boosting. Eventually passive immunization by sera from scFv-vccinated animals gave partial 
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protection to neonatal mice from experimentally transmitted disease with group B 
meningococci (Beninati et al., 2004).   
Anti-idiotypic monoclonal antibody (MAb), Naid60 was prepared which mimics the 
capsular polysaccharide (PS) against the sero-group B of Neisseria meningitidis (NMGB). 
Immunization with the Naid60-keyhole limpet hemocyanin resulted in the inhibition of the 
growth of the live Neisseria meningitidis sero-group B in mice, which were challenged 
intraperitoneally, about three of five control mice shown bacteremia. Naid60 was considered 
as an immunoprotective site that has the potential to elicit immune response with bactericida l 
action against Neisseria meningitidis. This study suggested the immunogenic region (Naid60) 
can be selected as a potential antigen for the production of a new successful vaccine against  
Neisseria meningitidis (Park et al., 2005).   
Anti-idiotypic antibodies, against prion disease demonstrated (Venturini et al., 2009) 
that, it is possible to induce a sturdy anti-idiotype immune response against the V5B2 
monoclonal antibodies in both xenogenic and syngenic experimental systems and determined 
that anti-Id antibodies achieved with well-defined immunization. The results pointed out, the 
humoral response evoked against pathological isoform of prion protein (PrPsc) that is target 
antigen.     
  
2.4. Current Review of pasteurellosis in Pakistan  
                Information based on field observations in nine districts of Punjab Pakistan presented 
11% incidence 9% mortality and 78% fatality reports of HS in buffalo while these numbers 
were 62%, 2.5% and 4% in cattle. The haemorrhagic septicaemia prevalence was greater in 
animals of the age of 0-24 months and in those groups in which animals were kept less than 
ten. Previous vaccination of animals using alum adsorbed formalinized broth culture of P. 
multocida vaccine (bacterin) did not shield animals against field outbreaks of HS (Sheikh et 
al., 1996).  
Oil base haemorrhagic septicaemia vaccine (OBHSV) induced higher level of 
antibodies than that of alum precipitated haemorrhagic septicaemia vaccine (APHSV). Both of 
the vaccines increased 2°F body temperature of the vaccinated rabbits where as temperature 
incepted declining to normal on 6 hours post vaccination. In the APHSV vaccinated rabbits the 
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peak levels of IHA antibodies GMT 1:55.7 was achieved on 45 days post vaccination that was 
24.3 on 90 days post vaccination. All the vaccinated rabbits showed 100% protection to 
challenge on 45 and 90 days post vaccination (Tariq et al., 1997). An oil adjuvanted vaccine 
prepared from P. multocida serotype 6: B was evaluated for immune response in cattle and 
buffaloes and its efficacy was compared with alum precipitated vaccine (Muneer et al., 2005). 
Comparatively higher titres by indirect enzyme linked immunosorbent assay (I-ELISA) were 
observed throughout the trial period i.e. 60, 120, 180, 240, 300 and 360 post vaccination days. 
While the titres in the animals vaccinated with alum precipitated vaccine (APV) declined after 
3 months post vaccination and reached minimal levels at 180 days post vaccination.  
The restriction endonuclease analysis (REA) technique was applied for analysis and to 
compare the eight field isolates and vaccinal strain of Pasteurella multocida by the use of Hha-
I enzyme. It was reported (Munir et al., 2006) that on the base of DNA finger prints, the extent 
of homology among the field isolates and the vaccinal strain was analyzed. Conventiona lly 
both types of serotyping somatic and capsular serotyping were done before prorein profiling. 
The experiment findings demonstrated clearly, that isolates of P. multocida were not same 
serologically, but genotypically all were same with the restriction enzyme used.   
A study was conducted on 50 rabbits, immunized against two oil adjuvanted and two 
alum precipitated vaccines of haemorrhagic septicemia disease (Naeem et al., 2006). The 
immune response was studied using IHA test. Maximum IHA geometric mean antibody titre 
of alum precipitated vaccine and alum adsorbed vaccine was 7.0 and 7.5 respectively on 45th 
day post vaccination. Oil based vaccines showed low antibody titres than alum precipitated 
vaccine up to 30th day. The increase in antibody titre was gradual up to 90 days post 
vaccination. IHA antibody was 8.0 on 45th day post vaccination but the titre was increased up 
to 12.1 on 90th day post vaccination.  
Eight isolates of P. multocida from HS cases were collected from various areas in 
Pakistan (Nawaz et al., 2006) were characterized by SDS-PAGE procedure. Sonification was 
done followed by centrifugation for the separation of the bacterial proteins. Salting out of the 
proteins obatined from the sonicated supernatant was performed by precipitation with 
ammonium sulfate. Analysis of the precipitated proteins and sonicated supernatant was carried 
out. The molecular weights of proteins were calculated graphically between log of molecula r 
weight and the Rf value. The samples treated with ammonium sulphate presented lesser bands 
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having less molecular weights of 54, 20.5, 42, 40 KDa, while in the supernatents overall 31 
visible bands were observed  that were sonicated and weighing from 111 to 126 KDa. The most 
common protein bands observed in both type of methods were 54 and 23 KDa.  
  It was studied that 30 pregnant cows were regularly vaccinated against haemorrhagic 
septicemia (HS) by the use of alum precipitated formalin killed HS vaccine (Mahmood et al., 
2007). The IHA antibody titres GMT in the sera of vaccinated dams, 15 days before the 
expected date of parturition and soon after parturition (before feeding colstorum to offspring) 
were detected 213 and 182 respectively. The antibody titres (GMT) of calves sera observed 
before the consumption of colostrum and then 6 hours, 3days, 15 days, 30 days, 45 days and 
60 post colostrum feeding were 44, 69 ,70, 97, 96, 72 and zero respectively, showing that the 
duration of maternal immunity to be 45 days in the experimental animals.  
Outer membrane proteins (OMPs) of B:2 strain of P. multocida were categorized by 
using  SDS-PAGE procedure. A total of 6 polypeptides extending from 15K Da to 91 KDa 
were detected (Munir et al., 2007) which showed two prominent bands of 39 and 32 KDa, also 
four less prominent bands of 44, 72, 91 and 15 KDa were observed. So these OMPs can be 
considered to recognize specific markers upto strain level that would form a useful foundation 
to distinguish them from field isolates of B:2 serotype of P. multocida  
The epidemiology of a respiratory syndrome was carried out at Landhi Dairy Colony 
(LDC), Karachi, Pakistan and its overall economic impact was estimated (Zahur et al., 2007). 
In this study 5889 buffaloes were examined, and found that 2.3% animals suffering from 
syndrome showed the clinical picture of haemorrhagic septicaemia. From the infected animals, 
P. multocida was isolated. An average of milk loss 10.07 litres per day per animal was 
observed. However, an average loss of Rs. 0.2 million per farm was recorded and the results 
were extrapolated and losses for 0.2 and 0.8 million animals present in LDC and related dairy 
colonies in Karachi were Rs. 225.6 and Rs. 1128.1 million, respectively.   
A study was carried out to observe inter-strain variation at molecular level in the two 
vaccinal types (B:3,4 and B:6) of P. multocida. Whole cell SDS-PAGE profiles showed 
similarities in the two vaccinal strains (Ullah et al., 2008). While SDS-PAGE profiles of 
envelope showed differences between the two vaccinal strains. The results explained that 85, 
27 KDa major and 70, 40 KDa minor proteins were common in both strains, where as the 50, 
32 and 29 KDa major proteins were found in B:3,4 but absent in B:6. The profiling of outer 
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membrane protein (OMPs) showed that 26 minor bands were common. The major proteins had 
50 and 32 KDa were observed in B: 3, 4 and absent in B:6, while 46 KDa minor protein was 
found in B:6 only.  
The prophylactic effect of levamisole in those buffalo calves which had been vaccinated 
for haemorrhagic septicemia (HS) was determined (Nadeem et al., 2010). The calves were 
administered with  0.5mg/kg body weight of levamisole two days before they were given the 
HS bacterin, showed geometric mean  serum IHA titres, 21.5 as compared to animals without 
receiving levamisole GMT of IHA titres was 14.79 and control group showed 2.5 GMT. 
Similarly lymphocyte proliferation assay (LPA) values ( 0.317 + 0.041 ) significantly higher 
in animals receiving levamisole, without levamisole was (0.049 + 0.003) while in control group 
was ( 0.043+ 0.002) at 14 days post vaccination.  
Efficiency of the hypertonic saline solution (HSS) was assessed along with nonsteroida l 
anti-inflammatory (NSAID) (Ketoprofen) and antibiotic (Ceftiofur HCl) for the treatment of  
(HS) in buffaloes. Those buffaloes were divied into two groups A and B, these were suffer ing 
from haemorrhagic septicaemia .Group A was kept as control and was recovered with Ceftiofur 
HCl (IM) and Ketoprofen injected intravenously with a dose of 6 and 2 mg/Kg body weight 
correspondingly, for five days (Zafar et al., 2010).  The group B was injected with I/V 
preparation of hypertonic saline solution, (7.5% NaCl) at a rate 4 ml/Kg body weight once, 
combined with Ceftiofur HCl and Ketoprofen. Experimental animals were observed for 24 
hours after start of treatment. The rate of survvial (80%) in group B was considerably higher 
(P < 0.05) than the rates of survival in group A (48%). While the group B showed the better 
recovery of heart and respiration rate. However, plasma volume was 98% which was brought 
back to nearly normal within duration of 24 hours past the inoculation of hypertonic saline 
solution to the animals of group B. It was declared that hypertonic saline solutions can help the 
antibiotic in combination with non-steroidal antiinflammatory drugs enhanced better 
respiration and pulse beat rates.  
Neutralizing antibodies were raised against P. multocida in the rabbit serum and these 
antibodies used as immunotherapy in P. multocida infected rabbits. In that study five rabbits 
were vaccinated with formalinized oil base vaccine three times at 21days interval. A high titre 
256 IHA unit was determined at 56th days post inoculation. This antibody titre was further 
enhanced as 1024 IHA unit with three consecutive inoculations with virulent P. multocida 
26  
  
suspension at 21 days interval. The hyperimmune serum 1ml (256 IHA units) was injected 
intravenously and intramuscularly to the P. multocida challenged rabbits, showed 100% and 
60% protection respectively, while antigen control group showed 0% protection. It was 
concluded that hyperimmune serum can be used passively as therapeutic to the HS infected 
animals simultaneously (Ahmad et al,. 2011) .  
  The sero-surveillance of HS was conducted in buffaloes and cattle. Average geometric mean 
titres (GMT) observed against HS in the diseased cattle and buffaloes were 5.7 and 6.1, 
respectively. (Farooq et al., 2011).  
A study was coducted regarding the outbreak of hemorrhagic septicemia in buffalo 
calves in Pakistan, recorded the mortality 31.48% (Khan et al., 2011). While mortality 
significantly peaked on 8th day (37%). The sign and symptoms were elevated body temperature 
(40.63+0.70°C), profuse salivation, dyspnea, respiratory sound rales, ocular discharge, mucus 
nasal discharge and restlessness were observed. Gross and histopathologically examinations 
conducted, an extensive lung edema, emphysema, thickened alveolar septa, congestion, and 
edema fluid in bronchioles were observed. Kidneys exhibited glomerulus atrophy, congestion, 
presence of casts in tubules along with pyknosis, condensation of nuclei and necrosis of tubular 
epithelium.  
The workers characterized the growth pattern of P. multocida on various carbon sources 
(Hussain et al., 2012). A field isolate of P. multocida Robert’s type-1 was grown on standard 
casein yeast extract media using glucose, maltose, galactose or sucrose as carbon source 
(0.3%). Higher cell mass yields were noted at 48, 32, 26 and 22 hours post inoculat ion, 
respectively for glucose, sucrose, maltose, and galactose. Furthetrmore carbon source 
concentration was increased from 0.3 to 1.0% and dry cell mass yields on glucose, fructose, 
maltose, galactose and sucrose were noted in shake flask culture. Maximum dry cell mass (gL-
1) was obtained when sucrose was used as carbon source followed by fructose. Specific growth 
rates of 0.319, 0.091, 0.183, 0.156 and 0.147 (h-1) respectively were noted on sucrose, glucose, 
fructose, maltose and galactose, respectively. Eventually, the cell mass forming volumetric rate 
was found to be significantly higher on sucrose compared with other sugars. While cell mass 
forming volumetric rate were 0.205, 0.202, 0.093, 0.124, 0.166 gL1h-1 on sucrose, glucose, 
fructose, maltose and galactose respectively.  
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The principal seed of the B: 2 strains of P. multocida were obtained in freeze dried form 
from VRI Peshawar, Pakistan. The reactivation was processed on brain heart infusion agar, and 
for re-isolation it was injected in rabbits. Within thirteen hours the rabbits died and by standard 
methods the isolate was identified. The Biomass production of P. multocida (Khan et al., 2013) 
was proceeded in order to assess the efficiency of the two methods. Using the conventiona l 
technique at 37ºC after 14 hours, maximum dry mass on brain heart infusion broth was 0.38 
g/10 ml, while it was 0.13 and 0.098 on both plain broth as well as nutrient broth 
correspondingly. While the optical density of the three nutrient media was tested and it was 
found that the brain heart infusion had the maximum optical density which was 1.577 at pH 7 
in comparison to the additional two nutrient media. The experiment exhibited that BHI is a 
extremely enriched media which facilitates the growth of Pasteurella multocida better when 
evaluated to others. The biofermenter result furnished a value of 2.1329 g/10 ml and it was 
much superior to conventional technique.  
  
  
  
  
  
  
  
  
  
  
  
  
  
CHAPTER III MATERIALS AND METHODS  
3.1. Collection of samples  
Cattle and buffalo livestock farms were focused on the two progressive districts of 
Faisalabad (located at 31.4180° N, 73.0790° E) and Chiniot (at 31.7200° N, 72.9789° E) with 
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agroclimate. The district Faisalabad having total population of buffalo (1.147 million heads) 
and cattle with 0.46 million heads while the Chiniot district reported the buffalo (0.27 million 
heads) and cattle with 0.97 million heads (Anonymous, 2010). The animal with respiratory 
distress and typical HS field cases were addressed during Monsoon season from July to August 
year 2011. The oral and nasal swabs were collected in the Tryptose Yeast Extract (TYE) broth 
along with blood samples. The standard strain of P. multocida type B: 2 (PM 2004) was 
procured from the Institute of Microbiology (University of Agriculture, Faisalabad).  
3.1.1. Processing of specimens   
Blood samples were processed for thin smear formation and stained with  
Giemsas’ stain for typical observation of bipolar characteristics. The specimens of oral and 
nasal swabs and morbid pieces of hearts, liver and lungs were also processed on the selective 
media including brain heart infusion (BHI) broth, blood agar, and casein sucrose yeast (CSY) 
agar, (Appendix I) as recommended by OIE (2008). The number of samples were collected is 
given in table (1).  
  
  
  
  
  
  
  
  
  
  
Table -1: The Collection of materials from Respirotry Distress Buffaloes and Cattle in 
the District of Chiniot and Faisalabad with number of Samples processed 
during the study.  
  
Serial.  
No.  
  
Animals  
Blood  
  
 Number of samples processed   
Nasal 
swabs  
Oral 
swabs  
Morbid  material  Total  
Pieces of  
Heart  Liver  Lung  
1  Buffaloes  110  23  30  12  10  15  200  
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2  Cattle  20  4  15  3  2  5  49  
Total  130  27  45  15  12  20  249  
  
3.2. Cultural characteristics  
Freshly isolated cultures were examined for detailed colony morphology on blood agar, 
CSY and TYE agar incubated at 37°C for 24 and 48 hours respectively.                     
 3.3. Morphological characteristics    
 The pure culture isolates belonging to Gram negative coccobacillus were taken up for detailed 
morphological characteristics on CSY selective media.  
3.4. Biochemical tests  
Indole, hydrogen sulphide production, Voges-Proskauer, methyl red reaction, nitrate 
reduction, sugar fermentation tests (incubated for 48 h) and catalase production as described by 
Krieg (1984) and for confirmation of culture isolates API-20 E (Analytical Profile Index for 
Enterococcus Biomeurix France ) were performed.  
3.4.1. Indole test   
 Few drops of xylene were added in a two day old growth of the isolate in two ml of peptone 
water and mixed thoroughly to dissolve indole and about 0.2 ml of Kovac’s reagent 
(Appendix1) was added. Pink layer of xylene was considered as positive reaction.  
  
3.4.2. Hydrogen sulphide (H2S) production  
 This test was performed for the ability to form black insoluble ferrous salt deposited on filter 
paper. The slants cultures were inoculated and incubated at 20°C for 7 days. It was inspected 
daily for blackening due to production of H2S.  
  
3.4.3. Voges-proskauer  
This test was processed in 48 hours old culture,  in 2 ml of peptone water containing  
0.5% dipotassium hydrogen phosphate by adding 0.2 mlof O ,Mera reagent (Appendix II) then 
30  
  
incubated in water bath at 37°C for 4 hours and aerated by shaking. Pink colour developed 
within two minutes in positive reaction.  
  
3.4.4. Methyl red   
This test was performed with peptone water similar for Voges-praskouer test. 
Inoculated medium was incubated at 37°C for 5 days. Few drops of methyl red reagent 
(Appendix II) were added and mixed properly. Bright red color developed in positive reactions.   
  
3.4.5. Nitrate reduction  
This was done by adding few drops of two days old broth culture in peptone water 
containing 0.1 per cent potassium nitrate and then incubated at37°C for two days. Presence of 
nitrate was detected by adding approximately one ml of sulfanilic acid and one ml of alpha 
naphthylamine reagent to nitrate broth culture. Development of a distinct red colour (which 
may turn to brown rapidly) was considered as positive test.  
3.4.6. Catalase test   
This test was performed by taking 2-3 drops of three percent hydrogen peoxide (H2O2) 
on clean grease free glass slide and single colony was mixed with the help of wire loop. 
Immediate formation of gas bubbles were considered as positive test.  
3.4.7. Sugar fermentation tests   
 Fermentation reactions of four sugars lactose, dulcitol, sorbitol and trehalose were studied. 
One per cent of each sugar in peptone water base with one per cent Andrade’s indicator 
(Appendix II) was used. Few drops of one-day growth of the isolates in peptone water were 
inoculated into each sugar and a thin layer of sterile liquid paraffin was spreaded over the 
medium. Tubes were incubated at 37°C for seven days and readings were recorded after every 
24 hours. Production of pink red color was considered as positive reaction. Proper controls 
were always kept for each of the sugar fermentation tests performed.  
  
3.5. In vitro antibiotic susceptibility test of P . multocida isolates  
The antibiotic susceptibility of all the isolated cultures was determined by disc diffus ion 
method using the Kirby-Bauer technique (Wimley and Hirstova, 2011) with minor 
modification. The surface of the blood agar containing plates was uniformly inoculated by 2 μl 
31  
  
bacterial suspension with equivalent turbidity to 0.5 McFarland standards. The isolates were 
tested against most commonly used antibiotics as given in table (2).  
Table 2.   The List of Antibiotics alongwith their Concentrations used to check in 
vitro susceptibility test  
Serial. No  Name of Antibiotic  Concentration ( μg)  
1  Ampicillin  10  
2  Ceftiofur  10  
3  Cephalexin  10  
4  Ciprofloxacin  5  
5  Florfenicol  30  
6  Norfloxacin  10  
7  Nitrofurantoin    300  
8  Ofloxacin  10  
9  Penicillin- G          10 units  
10  Tetracycline  30  
  
The zones of inhibition were measured after incubation for 24-48 hours at 37°C. The results 
were graded as Resistant (R) and Sensitive (S) according to the reference of particular 
antibiotic.  
3.6. Serotyping  
 To identify the culture serotype (capsular), a rapid slide agglutination test was performed with 
specific antisera (standard) for capsular serotyping, which was obtained from Institute of 
Microbiology UAF.  
3.6.1. Rapid slide agglutination   
 Single colony from a fresh culture plate was mixed with 5 drops of physiological saline on 
aglass slide and one drop of standard antiserum of P. multocida B: 2 was added. After mixing 
with a sterlized platinum loop the slide was gently warmed by waving over a flame. A positive 
reaction was observed by coarse, flocular agglutination occured with in 30 seconds with 
complete clearing background. All the haemorrhagic septicaemia isolates were performed for 
rapid slide agglutination test.  
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3.7. Molecular confirmation                                                                            
 Polymerase Chain Reaction (PCR) analysis for species specific identification of P. multocida 
B: 2 was performed as recommended by OIE, (2008).  
3.7.1. Genomic DNA Analysis  
  Pure P. multocida culture was inoculated in brain heart infusion broth (BHI) at 37°C for 
24 hours. This culture was used for DNA extraction.   
  
3.7.2. DNA Extraction Method  
 The broth culture of P. multocida was transferred to an Eppendorff tube and centrifuged at 
3000 X g for about 10 minutes. The pellet obtained after centrifugation was washed and re-
suspended in PBS and then centrifuged again. The final pellet was resuspended in 100 μl of 
distilled water. The mixture was boiled for 10 minutes in water bath and transferred 
immediately into ice and snap chilled for 30 minutes. The sample was then thawed and 
centrifuged at 3000 X g for 5 minutes. The supernatant was separated from pellet and used as 
template DNA (Antony et al., 2007).  
  
3.7.3. Preparation of Polymerase Chain Reaction (PCR) master mix  
PCR master mix 25µl was prepared as follows:  
H2O            13µl  
MgCl2    02µl  
dNTPs         01µl  
 Primer 1      01µl  
 Primer 2       01µl  
 Buffer           1.5µl  
Taq Polymerase  0.5µl  
 Total     20 µl  
Then 5µl of extracted DNA was added, and the final volume was made up to 25µl.   
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3.7.4. Polymerase Chain Reaction (PCR) Assay   
 PCR assay was conducted using thermalcycler, (Peq Lab Germany) for analysis of indeginous 
isolate type-B- specific P. multocida using the method described by Townsend et al., (1998). 
Briefly, the PCR assay for HS-associated type B serotype of Pasteurella multocida 
identification was performed through primer pairs of 16S species specific were applied these 
included KTSP61 and KTT72 serotype B of P. multocida. The primer sequences were:   
KTT72 5’-AGGCTCGTTTGGATTATGAAG-3'   
KTSP61 5'-ATCCGCTAACACACTCTC-3'   
The product size 560 base pair (bp) product was species specific and 760 (bp) was specific for 
serotype of P. multocida.  
 The thermal cycling parameters were used with the initial denaturation at 94°C for 5 minutes 
and fallowed by 30 cycles of 94°C for 1 minute, 53°C for 1 minute, and 72°C for 1 minute 
and final extension at 72°C for 9 minutes.  
3.7.5. PCR Analysis  
 Agarose gel running 2%, agarose gel was prepared in Tris Boric EDTA (TBE) buffer. 
Ethidium bromide (0.1%) was added and was mixed gently. After polymerization of the gel, 
samples were added to fill the wells dip. The gel tank was filled with 1X TBE buffer up to the 
wells dip and at a constant current of 80Volts was run. The final gel was viewed by UV trans-
illumination (Dolphin USA).   
3.8. Preparation of outer membrane proteins (OMPs)   
The outer membrane proteins (OMPs) were extracted by the Sarkosyl method (Choi et 
al., 1991). Briefly, P. multocida was grown in BHI broth (50 ml) for 18 h to obtain an activated 
culture. After morphological examination, the culture was expanded into 2 litres of BHIB 
(Appendix) supplemented with 5 % calf serum and incubated at 37°C under shaking conditions 
at 25 rpm / min for 24 h. The pure culture was harvested through centrifugation at 300 X g for 
15 min and washed once in sterile PBS. The bacterial cells were re-suspended in 10 mM 
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HEPES (pH 7.4) and disrupted by sonication (Ultrasonics, Ltd. Rapidis 600 USA). The cell 
debris was removed by centrifugation at 160 X g for 20 min and the sonicated supernatant was 
further centrifuged at 100,000 X g for 60 min at 4°C  (Himac CP 100  Hitachi , High Tech Lab 
University of Agriculture, Faisalabad). The resultant pellet was resuspended into 2 ml of (1% 
W/V) sodium lauryl sarcosinate in 10 mM HEPES (pH 7.4) and incubated at 22°C for 60 min. 
The insoluble OMPs were sedimented by centrifugation at 100,000 X g at 4°C for 60 min and 
the pellet was dissolved in PBS and stored at 20°C for future use.   
3.9. Estimation of protein concentration   
The concentration of OMPs total proteins was evaluated using the spectrophotometer 
(Hitachi U-1100, Japan) and as demonstrated by Bradford technique (1976).  
3.9.1. Procedure  
A 4- fold dilution of 2mg/ml bovine serum albumin (BSA) was prepared by adding  
50 µl of 2 mg/ml BSA to 150 µl of deionized water to make 200 µl of 0.5 mg/ml BSA.                        
Test samples were prepared for the reference cell, blank; BSA standards and the outer 
membrane protein (OMPs) were tested according to table (3) in disposable cuvettes.                          
The "reference cell" and "blank" were identical.   
Each sample was incubated at room temperature for 30 minutes.      
i) A double-beam UV-visible spectrophotometer was used for absorbance 
measurements with a range 0.2 - 0.8 O.D. units.  
ii) The spectrophotometer was warmed up for 15 minutes prior to use. The absorbance 
of each sample at 595 nm was measured.                                                           
The absorbance of each SA standard as a function of its theoretical concentration was 
plotted.                                                                                                                                                             
The data was determined to a straight line in the form of the equation "y = mx + b" where  
y = absorbance at 595 nm and x = protein concentration.                                                                      
The concentration of the protein was calculated based on the measured absorbance.                                          
35  
  
Table 3. Preparation of test samples for the estimation of proteins  
Test Sample  
Sample Volume 
ml  
Vol. Water 
ml  
Vol. Bradford 
Reagent (μl)  
Reference Cell  -  800  200  
Blank  -  800  200  
BSA Standard - 5 
μg/ml  
10  790  200  
BSA Standard - 10 
μg/ml  
20  780  200  
BSA Standard - 15  
μg /ml  
              30  770  200  
BSA Standard - 20  
μg /ml  
40  760  200  
BSA Standard - 25  
μg /ml  
50  750  200  
Protein Sample  50  750  200  
  
3.9.2. Analysis of outer membrane proteins  
The OMPs extracts were analyzed by sodium dodecyl sulphate- polyacrylamide gel  
Electrophoresis (SDS- PAGE) using the discontinuous buffer system of Laemmli (1970). It 
was performed in the molecular biology laboratory, department of Biotechnology UAF.  
  
3.10. Polyacrylamide gel electrophoresis analysis:   
3.10.1. Solution preparation for SDS-PAGE  
1. Tris Cl. 1.5m, pH 8.8:   
 Tris base 91 g was dissolved in 375 ml distilled water and the pH was adjusted to 8.8 and 
diluted to 500 ml with distilled water.  
2. Tris. Cl. 1M, pH 6.8:   
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  Tris base 30.5 g was dissolved in 175 ml distilled H2O and adjusted the pH to 6.8 and 
diluted to 250 ml with distilled water.  
3. Acrylamide (30%)  
  The distilled water was added to 100 ml with 29.2 g acrylamide, 0.8 g bisacrylamide, was 
filtered and stored in dark at 4oC.                                                          
4. TEMED (Aldarich, Sigma USA)  
5. Ammonium persulphate (10%) in distilled water.   
   Prepared as fresh.  
  
3.10.2. Preparation of gels  
 The plates were washed with water and rinsed with distilled water and then wiped with 
acetone. The spacers were put and taped on the gel plates.  
3.10.3. Preparation of running gel (5 %)  
In 100 ml beaker,   
19.75 ml distilled water was added,   
16.75 ml 30% acrylamide,   
12.5ml 1.5 M Tris.Cl (pH 8.8),    
500 µl 10% SDS,   
20 µl TEMED,   
A 500 µl ammonium persulphate solution (10%) and poured in the gel plates.  
A flat surface was created above the gel with distilled H2O.  
After polymerization (30 min) the distilled water was poured off.  
3.10.4. Preparation of Stacking gel (12%)  
Distilled water was added to 6.75 ml with,   
1.675 ml 30% acrylamide solution,   
1.25 ml 1MTris. Cl. (pH 6.8),   
100 µl 10% SDS,   
10 µl TEMED,   
100 µl 10% ammonium persulphate.  
The stacking gel (4ml for 1 cm) was poured and comb was inserted within the gel plates.                                 
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3.10.5. 4x Sample buffer                                                                                                              
The sample loading buffer was prepared as.  
0. 25M Tris Cl, pH 7,   
30% glycerol (v/v),   
10% 2-mercaptoethanol (v/v),   
8% SDS (w/v),   
0.001% bromophenol blue (w/v); to17.5ml   
12.5 ml1M Tris. Cl pH 7 added   
15 ml glycerol,   
5ml 2-mercaptoethanol,   
4g SDS and 2 mg bromophenol blue added and was stored at 4oC.  
  
3.10.6. Running buffer  
The running buffer was prepared by adding.  
25mM Tris,   
250 mM glycine,  
 0.1 % SDS (w/v) pH to 8.3 with HCl; to 700 ml   
Distilled H2O add 3.02 g Tris base,   
18.8 g glycine,   
A 10 ml 10 % SDS, pH was adjusted to 8.3 with HCl and the final volume was made to1 litre.  
3.10.7. Procedure                                                                                                                                    
 Both of the glass plates were washed thoroughly with warm water and liquid detergent and 
then rinsed with deionized water to remove detergent residues and wiped with tissue paper 
soaked in 70 percent alcohol. The glass plates were air dried by laying them on a whatman 
filter paper. The aligned edges and covered borders of glass plates on three sides were taped  
and clamped them using bulldog clamps. Ammonium per sulfate (200 μl) was added and 20 μl 
of TEMED to 20 ml PAGE mix and the gel was poured in the glass plates, filling the space 
almost to the top.  Once the solution was filled up, the comb was inserted in gel to the edge of 
the plate. Clamped with clips and kept in appropriate position till the gel got polymerized 
(approximately1hr). After acrylamide was polymerized, the clamp was removed by holding 
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the comb and casting stand togather, pulled out comb straight by wriggling it gently and 
smoothly. The stand was placed with assembly in the lower buffer reservoir of the PAGE 
apparatus tank.  
 The upper and lower tank was filled with 1X TBE buffer. The safety cover was fixed on top 
of the upper buffer chamber to prevent evaporation of buffer and pre run for 45 minutes at 
100V. A needle was used attached to the syringe filled with 1X-TBE buffer to flush out all the 
wells thoroughly.                                                                                                                         
  The samples (10 μl) was mixed with equal volume of sample loading buffer and kept for 5 
minutes at 95ºC.  The denatured samples were transferred immediately to ice to prevent 
annealing. The samples were loaded (20 μl) into each well and also loaded the ladder. After 
loading the denatured sample into the wells, the lid was placed on the upper buffer chamber. 
The gel was allowed to run at 100V for two hours. The plates were removed carefully from 
apparatus and kept on blotting paper. The spacers were removed and plates separated carefully 
using gel separator so that gel was retained on smaller plate.  The gel was washed with 
deionized water then gel was subjected to silver staining solution (50 ml for 1 hour) to visua li ze 
the bands. (Sharma et al., 2007). The staining solution was poured off and placed in destaining 
solution for 60 min., changing the solution every 15 min.                                                                   
3.10.8. Staining and destaining of gel   
   The staining of gel was done by using the silver staining kit by Fermentas.  
3.10.9. Fixing of gel   
   Fixing of the gel was performed with preparations of the solutions as detailed in  table 
(4).  
3.10.10. Staining solution  
 For the preparation of various solutions, the staining procedure required for essential solutions 
carrying the fallowing composition given in table (5). Table 4.  Detail of reagents and 
preparation of gel fixing solutions.  
Reagents  Gel fixing soln. 1  Gel fixing soln. 2  
Volume  Final conc.  Volume  Final conc.  
Ethanol  50ml  50% (v/v)  60 ml  30% (v/v)  
Glacial acetic acid  10 ml  10% (v/v)  -    
Water, ultra pure  40 ml    140 ml    
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Total volume  100 ml    200 ml    
  
Table 5 . Detail of reagents and preparation of staining solutions for gels.  
Reagents  Sensitizing 
solution  
Staining 
solution  
Developing 
solution  
Stop 
solution  
Sensitizing 
concentrate  
  
0.4 ml  
---    
10 µl  
---  
Staining reagent  ---  4 ml  ---  ---  
Developing 
reagent  
---  ---    
10 ml  
---  
Stop reagent  ---  ---  ---  8 ml  
Water, ultrapure  To 100 ml  To 100 ml  To 100 ml  92 ml  
Formaldehyde  ---  54 µl*  27 µl*  ---  
Total volume  100 ml  100 ml  100 ml  100 ml  
.  Added immediately prior to use.  
  
  
  
Precautions  
 While working in the Molecular Biochemistry Laboratory UAF facilities, all the critica l 
precautions were strictly observed which were included.  
1. The gel to be stained should never be in contact with hands or metal objects.  
2. Wear rinsed gloves.  
3. For best results the solutions should be prepared the same day prior to staining.   
4. Add the formaldehyde only immediately prior to staining.  
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 i)  Gel fixing 1  
 The gel was placed into a staining tray and rinsed with deionized water. A100 ml of gel fixing 
solution 1 was added and gently agitated for 10 min.  Gel fixing solution 1 was discarded.   
  
(ii) Gel fixing 2 and washing:  
 A 100 ml gel fixing solution 2 was added and gently agitated for 10 min. Gel fixing solution 
2 was discarded. The same procedure was repeated. A 100 ml of deionized water was added 
and gently agitated for 20 seconds. The water was discarded. The washing was done twice.   
  
(iii) Sensitizing and washing                                                                                                                 
A 100 ml of sensitizing solution was added and gently agitated for 1 min.  
The sensitizing solution was discarded.                                                                                             
A 100 ml of deionized water was added and gently agitated for 20 seconds.                                            
The water was discarded. The washing procedure was done twice.  
  
(iv)  Staining and washing  
A 100 ml of staining solution was added and gently agitated for 20 min.  
The staining solution was discarded.  
A 100 ml of deionized water added and gently agitated for 20 seconds The 
water was discarded. The washing performed twice.  
(v) Developing  
A 100 ml of developing solution was added and gently agitated for 20 minutes until bands      
were well developed and the required intensity was reached. The developing solution was 
discarded.  
  
(vi) Terminating   
 A 100 ml of stop solution was added and gently agitated for 10 minutes.  
The stop solution was discarded. (Silver staining kit, user’s protocol, 2007)   
  
(vii) Sizing of the OMPs  
The sizing of the OMPs was carried out with the help of Gene Tool analysis software.  
 A protein molecular weight marker was used to compare the size of OMPs.    
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3.11. Preparation of adjuvanted OMPs  
The purified outer membrane proteins (OMPs) prepared previously as detailed in  
3.8 was diluted in PBS as detailed below.  
A- 0.1, 0.5, 0.7, 0.9 and 1.0 mg/ml  
B- 0.1, 0.4, 0.8, 1.2 and 1.6 mg/ml  
One ml of each diluted OMPs was mixed with one ml of Montanide-ISA70 and stored 
at referigiration temperature for further use.  
3.11.1. Immunization of Rabbits  
Pasteurella-free 10 week old male Chinchilla breed of rabbits weighing 2.5-3.4 kg, 
were reared in the faculty of Experimental Animal Housing, Institute of Microbiology UAF. 
Before immunization, nasal cavity contents of each rabbit were cultured three times for the 
presence of P. multocida. All the rabbits were sampled for the detection of serum antibod ies 
against P. multocida using indirect haemagglutination (IHA) test and confirmed for sero-
negativity. For the prepartion of idiotype, two groups of rabbits (15 in each group) were 
immunized with adjuvanted OMPs described by (Shoung Lu et al., 1991) and as scheduled in 
table (6)  
Table 6.  Inoculation Schedule of purified and adjuvanted P. multocida OMPs in two 
groups of Rabbits.  
Group No.  Days  Dose  Group No.  Dose  Route  
  
  
      R1  
1  0.1 mg    
  
R2  
0.1 mg  S/c  
4  0.5 mg  0.4 mg  S/c  
7  0.7 mg  0.8 mg  S/c  
10  0.9 mg  1.2 mg  S/c  
13     1 mg  1.6 mg  S/c  
    
The serum was collected at 14 days after last inoculation in both groups and stored at -
20°C. The serum was titrated for IHA antibodies.  
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3.12. Indirect haemagglutination test (IHA)  
 Serum samples were processed for antibody titration through indirect haemagglutinat ion 
(IHA) test as described by (OIE, 2008) with minor modifications.  
3.12.1. Washing of Red blood cells  
 Briefly, sheep blood was collected aseptically into a test tube with 4% sodium citrate as an 
anticoagulant and centrifuged at 500 Xg for 10 minutes. The supernatant was discarded while 
packed RBCs were washed three times in PBS..   
3.12.2. Sensitization of Red blood cells  
 The extracted, purified OMPs of P. multocida (B: 2) strain was used to sensitize the RBCs. 
Briefly, washed sheep RBCs were sensitized with cromimum chloride  falowing the method 
of (Banasal et al ., 1986) briefly one volume of chromium chloride  (1:4000) vernel buffer with 
two volume of 5%  washed RBC and two volumes of OMPs. The suspension was incubated 
for 1 hour at 37°C was centrifuged at 1500 rpm for 5 minutes and supernatent was discarded. 
The packed cell volume was washed three times in sterile PBS and made up to a final 1% 
suspension in PBS.  
3.12.3. Procedure  
Microtitration plates were used for IHA test.  
1. A volume of 50 µl of PBS (pH 7.2) was dispensed in to well no. 1-12.  
2. In the first well, 50 µl serum samples was added and made two fold dilutions up to 11th well 
and from the 11th well 50 ul was discarded.  
3. Two fold serial dilution of the serum (1:2 to 1:1024) was prepared.  
4. A 50 µl quantity of 1% suspension of sensitized sheep RBCs was added in well 1-12  
5. Well 12 was kept as control containing only normal saline and RBCs suspension.  
6. The plates were covered and incubated at 37°C for 15 minutes.  
7. The first reading is taken after 2 hours and a final reading after 18 hours. A course 
agglutination of the RBCs along the sides of the concave wells is taken as a positive reading, 
and the formation of a button at the centre of the wells as negative.   
The IHA antibody titre of each sample was narrated as the reciprocal of its end point 
dilution. Thus the IHA antibody titre of all serum samples was recorded.   
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3.12.4. Determination of geometric means titre (GMT)  
Two fold serial dilutions were used, beginning with serum diluted1:2 (equal parts 
undiluted serum and diluent). The tube or dilution number in the series equals the true log2, 
which is the reciprocal of the highest positive dilution factor, and the log2 titre corresponds to 
the highest tube number showing the desired reaction. Calculation of geometric means titres 
are related to titration end points as tube or dilution number. The mean titre equals the sum of 
the end points divided by the number of samples tested. GMT can be determined based on 
reference table (Brugh, 1978). The cumulative GMT is obtained through decimal mathematica l 
calculation within the same group individually  
  
3.13. Separation and preparation of Fab  
  The rabbit’s serum was subjected to precipitation using ammonium sulphate method (Stec 
et al., 2004).  
3.13.1. Ammonium sulphate precipitation method   
 The precipitation was performed at 4°C. Equal volumes of diluted serum and saturated 
ammonium sulphate were mixed by slow addition of the ammonium sulphate solution during 
gentle stirring. On the next day this material was centrifuged (10, 000 X g for 20 min) and 
washed twice with 50% saturated ammonium sulphate solution. The precipitate was dissolved 
in distilled water and dialyzed against phosphate buffer. The final solution was filtered through 
a millipore filter (0.22 μm), and immunoglobulins contents wers obtained.  
  
3.13.2. Separation of Fab  
 
   The immunoglobulins (IGg) were transferred into 0.2M sodium acetate buffer  
(SAB) (pH 4.0) by dialysis. The IgG concentration was adjusted to 2mg/ml (Gauci and 
Alderton 2001). The IgG digestion was completed by using an equal volume of pepsin solution 
prepared in SAB and making a final (w/w) ratio of pepsin to antibody (E: A) 1:100. The 
resultant enzyme/antibody mixture was incubated at 37°C for 4 hours. Finally the products 
were confirmed on gel electrophoresis to confirm the molecular weight protein of (110) 
kilodalton.  
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3.14. Immunization of Sheep for anti-idiotype preparation  
  
 The semi purified Fab (adjuvanted) was inoculated in two groups of Sheep S1 and S2 (5 Sheep 
in each group), with S/c route at the doses 1mg, 1.25mg and 0.5 mg with intervals of 3 days in 
group S1. Similarly, the doses of purified Fab (adjuvanted) 1.25mg, 1.5mg and 0.5mg were 
inoculated in group S2. The serum of both groups of sheep was collected at 14 days after last 
inoculation and was stored at -20°C. The IgG fractions obtained from serum of sheep were 
determined by electrophoresis and the Fab was purified in the same way as mentioned 
previously. The anti-idiotype was mixed with Montanide ISA70 adjuvant and the vaccine was 
stored at refrigeration temperature for further use.  
3.15. Source of Bacterin   
  
 The formalinized alum precipitated bacterin was used from VRI Lahore as a control vaccine 
for the comparison with the experimental vaccines.   
  
3.16. Preparation of Subunit OMPs vaccines   
  
 Outer membrane proteins content separated from P. multocida indigenous spp. serotype was 
mixed with equal volume Montanide ISA 70 adjuvant. Final concentration was made as 133.3 
ug /ml and was used for comparative evaluation studies.   
  
3.17. Sterility tests  
 Sterility test was performed in thioglycollate (Appendix III) broth and on blood agar plate. 0.1 
ml of each vaccine was inoculated separately and was observed after every 24 hours for seven 
days at 37°C for any growth. Sterility was also checked for any growth of anaerobic bacteria.   
 3.18. Safety tests    
 Safety studies were performed for each vaccine in three groups of rabbits (five in each group) 
which were separately inoculated subcutaneously with 2 ml of vaccines at divided portions in 
the neck region. Observations on daily body temperature, local inflammation at the site of 
inoculation, food and water intake, weight acquired and reduced and morbidity were recorded 
up to 7 days post inoculation.  
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3.19. Experimental trials of bacterin, OMPs and anti-idiotype H. S.  
vaccine in buffaloes  
  
 The three groups of buffalo calves (B1, B2 and B3) Nili Ravi breed, 1-2 years age having 10 
heads in each group maintained in district Chiniot livestock farms, group B1 was inoculated 
with plain bacterin, group B2 with alone subunit OMPs vaccine at the dose 400µg/100kg b.wt. 
S/c (Opacka and Kedrak 2003). Group B3 was inoculated with alone anti-idiotype vaccine with 
the same doses as group B2. The details are given in table (7). First serum sample was collected 
before vaccination then serum collection was continued on monthly basis up to 370 days post 
vaccination and was stored at 20°C.  
  
  
  
  
  
  
Table.7. Experimental Trials of Experimental Vaccines in Various Groups of Buffaloes and 
Cattle Farms located in District Chiniot    
Group. No  
Type of 
Animals  
No. of 
Vaccinates  
Location of 
Farms  
Type of 
Vaccine  
Dose  
400μg  
/100kg  
Route  
B1  
Buffalo 
Calves  
5  
Ahmad Livestock  
Farm.Kot Amir  
Shah District 
Chiniot  
Bacterin  
3ml  
S/c  
5  
Tathi Khuda Yar 
Distric Chiniot  
3ml  
B2  
Buffalo 
Calves  
5  
Kot Wasawa    
Distric Chiniot  
Subunit  
3ml  
S/c  
5  
Methrooma   
District Chiniot  
3ml  
B3  
Buffalo 
Calves  
5  
Naseerabad  
District Chiniot  
Antiidiotype  3ml  S/c  
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5  
Jahlar Wahab 
Shah District 
Chiniot  
3ml  
C1  
Cattle 
Calves  
5  
Kot Amir Shah  
District Chiniot  
Bacterin  
3ml  
S/c  
5  
Chianiyan District 
Chiniot  
3ml  
C2  
Cattle  
Calves  
5  
Methrooma   
District Chiniot  
Subunit  
3ml  
S/c  
5  
Tathi Khuda Yar 
District Chiniot  
3ml  
C3  
Cattle 
Calves  
5  
Ahmad Nagar  
Distric Chiniot  
Antiidiotype  
3ml  
S/c  
5  
Ahmad Livestock  
Farm.Kot Amir  
Shah District 
Chiniot  
3ml  
  
3.20. Experimental trials of bacterin, OMPs and anti-idiotype H. S.  
vaccine in cattle                                
 The three groups of cattle calves (C1, C2 and C3) Sahiwal breed, 1-2 years age having 10 
heads in each group maintained in district Chiniot livestock farms detailed in table (7) group 
C1 was inoculated with plain alum precipated HS bacterin, C2 with alone subunit OMPs 
vaccine at the dose 400µg/100kg b.wt. S/c and group C3 was injected with alone anti-idiotype 
vaccine at same dose rate as group C2. First serum sample was collected before vaccinat ion 
then serum collection was continued on monthly basis up to 370 days post vaccination and was 
stored at -20°C.  
3.21. Challenge/protection studies of vaccinated animals  
 Three animals from all groups were challenged with pathogenic indigenous P. multocida 109 
CFU by nasal spray at 160 days post vaccination. Severities of inflammation, health and body 
temperature along with signs /symptoms were checked up to one month post challenge.  
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3.22. Detection of immune response  
Serum samples of all experimental groups of animals were processed for antibody 
titration through indirect haemagglutination (IHA) test as described by (OIE 2008) with minor 
modifications.  
3.23. Statistical analysis  
Geometric means antibody titres were calculated statistically and comparison of means 
was analyzed for bacterin, subunit OMPs and anti-idiotype HS vaccine among all groups of 
buffaloes and cattle. Fischer-Exact test was used to check significance of protection/challenge 
test. SPSS soft ware was used.  
  
  
  
  
  
  
  
  
 CHAPTER IV     
RESULTS  
4.1. Culture characteristics of P. multocida  
A total of 249 speciemen samples were processed as detailed in table (8) for culture isolation 
and most of these samples showed turbidity (48%) in brain heart infusion broth (BHI) results 
are depicted in table (9). In BHI broth, the observed growth of P. multocida showed turbidity 
with straw colour and homogeneous suspension after 24-h of incubation. The culture on blood 
agar were mostly positive (30%) with or without haemolytic characteristic shown in table (10) 
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on blood agar surface, the colonies were small, spherical and translucent, with light gray color 
and smooth surface, having a non-haemolytic appearance after 48-h of incubation. Among the 
cultures having Gram negative coccobacilli morphological characters were propagated on 
tryptose yeast extract (TYE) agar. Typical colonies of circular shape, irregular edges, straw 
coloured with 0.5-2 mm diameter were visualised. These cultures were further redirected which 
turned out to become negative on MacConkey’s agar plates. The culture remained negative on 
MacConkey’s agar plates even after 72 hours of incubation, which indicated typical P. 
multocida. The culture growth was further confirmed on casein sucrose yeast(CSY) agar with 
the appearance of typical well-developed colonies consisting of a smooth surface, grayish 
white colour, and circular shape with entire  border, as observed after 48-h of incubation  
  
  
  
  
  
  
  
  
  
  
Table. 8. Isolation of P. multocida from samples processed.  
Type of sample  Type of animals  Number of samples  
Blood  Buffaloes  
Cattle  
110  
20  
Nasal swabs  Buffaloes  
Cattle  
23  
4  
Oral swabs  Buffaloes  
Cattle  
30  
15  
Tissues  Buffaloes  
Cattle  
37  
10  
Total    249  
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Table.9. Specimen wise Recovery percentage of culture isolates obtained from 
Respiratory distress cases of Cattle and Buffaloes during studies.  
Type 
of  
sample  
Type of 
animal  
No.of 
samples  
Growth 
on  
BHIB  
Growth  
on  
Blood 
agar  
Growth 
on CSY 
agar  
Growth 
on TYE 
agar  
Gram -ve 
coccobaccilli 
isolates  
  
Blood  
Buffaloes  
  
110  
  
28  
(25%)  
30  
(27%)  
12  
(11%)  
15  
(14%)  
6  
 (5%)  
Cattle  20  
12  
( 60%)  
10  
(50%)  
2  
(10%)  
5   
(25%)  
  
Nasal 
swabs  
  
Buffaloes  
  
23  
12  
(52%)  
11  
(47%)  
6 
(26%)  
3 
(13%)  
2 
(9%)  
Cattle  4  
2  
(50%)  
1   
(25%)  
-  -    
Oral 
swabs  
  
Buffaloes  
  
30  
25  
(83%)  
-  
18  
(60%)  
8   
(27%)  
  
Cattle  15  
9   
(60%)  
3  
(20%)  
5   
(33)%  
4  
(27%)  
  
  
Tissues  
  
Buffaloes  
  37  
24  
(65%)  
15  
(41%)  
14  
(38%)  
7  
(19%)    
Cattle  10  
8  
(80%)  
4  
(40%)  
6  
(60%)  
-    
Total  
  
  249  
120  
(48%)  
74  
(30%)  
63  
(25%)  
42  
(17%)  
8 
(3%)  
  
  
  
  
Table. 10. Cultural characterzation of the P. multocida isolates.  
Culture 
No.  
          Blood agar  Tryptose Yeast Extract   
(TYE)agar  
Casein Sucrose Yeast                 
(CSY) agar  
Colony 
morphology  
Colony 
diameter  
Colony 
morphology  
Colony 
diameter  
Colony 
morphology  
Colony 
diameter  
5 BC  Translucent, 
grayish  light 
yellow  
  
0.5-  
0.7mm  
Circular  
light straw 
colour  
0.8-     
1.5 mm  
Grayish bright  0.7-  
 1 mm  
50  
  
35 BC  Translucent, 
grayish white  
0.7-  
 1mm  
Circular 
straw  pale 
colour  
 0.5-   
1.7 mm  
Grayish dark  0.6-  
 1 mm  
36 BC  Translucent, 
grayish pale  
0.5-   
1 mm  
Circular, 
dark straw 
colour  
 0.9-  
2 mm  
Grayish white 
creamy  
0.9-   
1.5 mm  
10 BF  Smooth, 
grayish white  
0.6-   
0.8 mm  
Circular 
straw colour 
light golden  
0.8-  
1mm  
 Light grayish 
white  
 0.5 -  
0.8 mm  
12 BF  Translucent, 
grayish dark  
 0.7-  
 0.9 mm  
Circular  
bright straw 
colour  
0.5-   
2 mm  
 Smooth 
grayish white  
0.5-  
 1.5 mm  
16 BF  Translucent, 
grayish white  
0.5-    
0.6 mm  
Circular 
straw colour  
 0.5-  
1.5 mm  
Grayish white  0.8-  
 2 mm  
40 BF  Translucent, 
grayish light 
golden  
0.8-  
 1mm  
Circular  
light straw 
colour  
0.8-  
 2 mm  
 Bright grayish 
white  
 0.5-  
1.4 mm  
51 BF  Translucent, 
grayish yellow  
  0.5-  
0.9 mm  
Circular light 
yellow 
colour  
0.7-  
 1.5 mm  
Grayish dark  0.5-  
 1mm  
PM  
2004  
Translucent, 
grayish white  
0.5- 1mm  Circular  
dark straw 
colour  
0.9-  
 2 mm  
Light grayish 
white  
0.7-  
 2 mm  
  
  
  
4.2. Microscopic examination  
The growth obtained after 24 hours of incubation in BHI broth, blood agar and CSY agar 
showed cells consisting of Gram negative coccobacilli surrounded by a transparent zone of 
capsule. Giemsa’s stain confirmed the typical appearance of bipolar characteristics from the 
blood agar. The results are presented in plate (1and 2) and table (11).     
51  
  
 
  
Plate No.1 Results of Gram staining of tle isolates showing red bacterial cells with 
pleomorphic charecteristics of coccobacilli (rod shaped) image (960X).  
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Plate No.2.  Results of Capsular staining (Copper sulphate) showing blue color bacterial 
cells surrounded by opaque zone of capsule of P. multocida (5BC)  (960X)  
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Table.11. Morphological Characterization of the P.multocida isolates with different 
Staining Methods.  
Culture. No  Gram staining    
Capsule  
Staining  
Giemsa's 
staining  
Morphology  
5 BC  -tive  Present  Bipolar  Coccobaccili  
35 BC  -tive  Present  Bipolar  Coccobaccili  
36 BC  -tive  Present  Bipolar  Coccobaccili  
10 BF  -tive  Present  Bipolar  Coccobaccili  
12 BF  -tive  Present  Bipolar  Coccobaccili  
16 BF  -tive  Present  Bipolar  Coccobaccili  
40 BF  -tive  Present  Bipolar  Coccobaccili  
51 BF  -tive  Present  Bipolar  Coccobaccili  
PM 2004  -tive  Present  Bipolar  Coccobaccili  
    
4.3. Biochemical characteristics  
Pure growth of P. multocida from CSY agar was positive for indole, catalase, hydrogen 
sulphide production and nitrate reduction, while Voges-Proskauer and methyl red reactions 
were negative, the results are shown in table (12). The growth was found to be negative for 
lactose and dulcitol fermentation, whereas trehalose and sorbitol were fermented without gas 
formation. The results are presented in table (13) and identification of isolates through API 20 
E, presented in plate (3) and table (14).  
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Table. 12. Results of Biochemical tests /Enzyme production Characterization of isolates 
recovered from Respiratory disease cases of Cattle and Buffaloes.  
Cultre.No  Indole  
Voges-  
Proskauer  
  
  
Methyl 
red  
  
  
Catalase 
production  
  
Hydrogen  
Sulphide 
production  
Nitrate 
reduction  
5BC  +tive  -tive  -tive  +tive  +tive  +tive  
35BC  +tive  -tive  -tive  +tive  +tive  +tive  
36BC  +tive  -tive  -tive  +tive  +tive  +tive  
10BF  +tive  -tive  -tive  +tive  +tive  +tive  
12BF  +tive  -tive  -tive  +tive  +tive  +tive  
16BF  +tive  -tive  -tive  +tive  +tive  +tive  
40 BF  +tive  -tive  -tive  +tive  +tive  +tive  
51 BF  +tive  -tive  -tive  +tive  +tive  +tive  
PM 2004  +tive  -tive  -tive  +tive  +tive  +tive  
Table.13. Results of Sugar fermentation Characterization of the P. multocida isolates and 
comprared with Strandard strain.  
  
Culture. No  
  
Lactose with 
gas  
  
Dulcitol  
  
Sorbitol  
  
Trehalose  
5BC  
-tive  -tive  +tive  +tive  
35BC  
-tive  -tive  +tive  +tive  
36BC  
-tive  -tive  +tive  +tive  
10BF  
-tive  -tive  +tive  +tive  
12BF  
-tive  -tive  +tive  +tive  
16BF  
-tive  -tive  +tive  +tive  
40 BF  
-tive  -tive  -tive  +tive  
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51 BF  
-tive  -tive  +tive  -tive  
PM 2004  
-tive  -tive  +tive  +tive  
  
  
Table. 14. The result of API-20E of the P. multocida isolates with similarity index 
Identification marks.  
Culture #  API- 20 E   
ID #   
  
Percentage  
ID   
  
Species Identification   
  
5BC  
144524   
  
99.9 %   
  
Pasteurella multocida   
  
35BC  
144524  99.9 %   
  
Pasteurella multocida   
  
36BC  
140520   
  
99.9 %   
  
Pasteurella multocida   
  
10BF  
140524   
  
99.9 %   
  
Pasteurella multocida   
  
12BF  
144524  99.9 %   
  
Pasteurella multocida   
  
16BF  
144524  99.9 %   
  
Pasteurella multocida   
  
40 BF  
 144024  
  
87.7%   
  
Pasteurella multocida   
  
51 BF  
104024  79.5%   
  
Pasteurella.pneumo/haemo   
  
PM 2004  
140520   
  
99.9 %   
  
Pasteurella multocida   
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P. multocida (PM 2004) culture  
  
  
  
  
Culture NO. BF 40  
  
  
  
  
Culture NO. BF 51  
Plate No.3.  Strips of API-20E of two cultures tested and compared with standard culture  
for their biochemical, enzymes and sugar fermentation results of P. 
multocida isolates.   
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 4.4. PCR Product Analysis    
The PCR product amplified 560 and 760 base pairs as depicted in plate no. (4).  
  
 
 
760 bp  
560 bp  
 
                M        L1       L2         L3       L4        L5          L6          L7  
  
Plate No. 4. Specific confirmation of P. multocida (560 bp) and serotype B: 2 (760 bp) as 
indicated through polymerase chain reaction illustrating specific amplified products on agarose 
gel electrophoresis. Sample No L1, L4, and L7 showing positive bands indication.  
[M=marker, L1=PM 2004, L2=internal control (without DNA), L3= BC35, L4=BF51,  
L5=BF40, L6= external control E .coli DNA, L7=BC5 ]  
  
    
4.5. In vitro antibiotic susceptibility tests of P. multocida isolates  
The results of antibiotic susceptibility are depicted in tables (15 and 16. Among the eight 
isolates studied all of them (100%) were sensitive to Florfenicol and Cephalexin, while 50 per 
cent were sensitive to Tetracycline, Ampicillin and Nitrofurantoin. All the isolates (100%) 
were resistant to Penicillin-G and 87.5 % to Ofloxacin and 75 % to Ceftiofur, Norfloxacin and 
Ciprofloxacin.  
  
  
58  
  
Table. 15. Antibiotic susceptibility test of individual isolate of P. multocida showing 
average diameter zone (mm) for various culture isolates of Pasteurella multocida 
recovered from field cases of bovine respiratory infections.  
Serial. 
No  
Name of  
antibiotics  
  
                   Pattern of sensitivity with isolates (Cultute. No.)               
5BC  
diameter  
35BC  
diameter   
36BC  
diameter   
10BF  
diameter  
12BF  
diameter  
16BF  
diameter  
40 BF  
diameter  
51 BF  
diameter  
1  Ampicillin  S  
(7.4mm)  
S  
(7.4mm)  
R  
(6.2mm)  
S  
(7.4mm)  
R  
(6.1mm)  
R  
(6.3mm)  
R  
(6.4mm)  
S  
(7.8mm)  
2  Ceftiofur  R  
(6.1mm)  
R  
(6.4mm)  
R  
(6.3mm)  
R  
(6.3mm)  
R  
(6.2mm)  
S  
(7.4mm)  
S  
(7.6mm)  
R  
(6.1mm)  
3  Cephalaxin  S  
(7.5mm)  
S  
(7.8mm)  
S  
(7.6mm)  
S  
(7.5mm)  
S  
(7.4mm)  
S  
(7.4mm)  
S  
(7.8mm)  
S  
(7.8mm)  
4  Ciprofloxacin  R  
(6.2mm  
S  
(7.5mm)  
R  
(6.3mm)  
R  
(6.4mm)  
S  
(7.5mm)  
R  
(6.1mm  
R  
(6.1mm)  
R  
(6.4mm)  
5  Florfenicol  S  
(7.8mm)  
S  
(7.4mm)  
S  
(7.6mm)  
S  
(7.5mm)  
S  
(7.8mm)  
S  
(7.6mm)  
S  
(7.7mm)  
S  
(7.8mm)  
6  Norfloxacin  R  
(6.4mm  
R  
(6.2mm  
S  
(7.4mm)  
R  
(6.2mm)  
R  
(6.1mm)  
R  
(6.1mm)  
S  
(7.5mm)  
R  
(6.3mm)  
7  Nitrofurantoin  S  
(7.4mm)  
S  
(7.5mm)  
R  
(6.2mm)  
R  
(6.1mm)  
R  
(6.3mm)  
S  
(7.4mm)  
R  
(6.2mm  
S  
(7.4mm)  
8  Ofloxacin  R  
(6.2mm  
S  
(7.8mm)  
R  
(6.4mm  
R  
(6.2mm)  
R  
(6.2mm)  
R  
(6.3mm)  
R  
(6.2mm)  
R  
(6.4mm)  
9  Penicillin- G  R  
(6.2mm)  
R  
(6.1mm)  
R  
(6.2mm)  
R  
(6.4mm)  
R  
(6.2mm)  
R  
(6.3mm)  
R  
(6.2mm)  
R  
(6.1mm)  
10  Tetracycline  S  
(7.6mm)  
R  
(6.4mm)  
S  
(7.4mm)  
R  
(6.2mm)  
S  
(7.8mm)  
R  
(6.3mm)  
R  
(6.4mm)  
S  
(7.5mm)  
  
  
  
  
  
  
Table.16. Percentage profile of antibiogram analysis with respect to the isolates of P.  
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multocida (n=8 ).   
Antibiotics  Resistant  Sensitive  
Ampicillin  4 (50 % )  4 (50 %)  
Ceftiofur  6 (75 %)  2 (25% )  
Cephalaxin  0 (0 %)  8 (100 %)  
Ciprofloxacin  6 (75 %)  2 (25 %)  
Florfenicol  0 (0 %)  8 (100 %)  
Norfloxacin  6 (75 %)  2 (25 %)  
Nitrofurantoin  4 (50 %)  4 (50 %)  
Ofloxacin  7 (87.5 %)  1 (12.5 %)  
Penicillin-G  8 (100 %)  0 (0 %)  
Tetracycline  4 (50 %)  4 (50 %)  
  
4.6. Profiles of Outer membrane protein (OMPs) of Pasteurella multocida isolates  
4.6.1 Separation of OMPs  
By using Sarkosyl method the OMPs of isolates of P. multocida isolates and PM 2004 strain 
were extracted. The concentration of protein in the OMPs rich extracts was estimated and it 
revealed that the protein content of purified OMPs obtained was 21.30 mg/100 ml.  
4.6.2. Characterization of outer membrane proteins (OMPs)  
Electrophoretically, OMPs of P. multocida isolates (6) and one strandard strain were   resolved 
on SDS PAGE (12%). The six isolates of buffalo and one standard strain related to capsular 
type B: 2.  
4.6.3. OMPs profiles of isolates with capsular type B: 2  
Six isolates from buffalo and one capsular type B: 2 standard strains were analyzed for OMPs 
profile. The protein profiles confirmed the presence of four protein band pattern of about 32 to 
90 KDa depicted in plate (5). The band patterns of all the buffalo isolates, (5BC, 35BC, 36BC, 
10BF, 12BF and 16BF) revealed the presence of three common intense bands with molecular 
weight of  90, 72,  and 32 KDa  and one common light band with molecular mass of 44 KDa.  
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                            SM        M         1            2          3         4         5        6        7  
  
Plate.No.5. SDS-PAGE profiling after silver stained six isolates of P. multocida and 
standrad strain, the band ranged up to 90 KDa molecular weight of OMPs 
(SM=Standard marker, M=marker, 1-7= test culture isolates).   
  
4.7. IHA Titres of hyperimmunized Rabbits  
 The IHA antibodies titres of hyperimmunized rabbits of group R1 were ranged from 1:128 to 
1:512 with a geomean titre of 1:222.9. Similarly the rabbits of group R2 showed the titres 
from1:128 to 1:512 with a higher IHA geomean titre of 1: 238.9. The results are presented in 
table (17).  
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Table .17. Results of IHA antibodies Titres of two groups of Rabbits Hyper immunized 
with P.multocidaOMPs adjuvanted  
  
  
  
IHA antibody titres  Group. No  IHA antiboy titres  
  
  
  
  
  
  
  
  
RI  
1:128    
  
  
  
  
  
          R2  
1:512  
1:256  1:256  
1:256  1:128  
1:512  1:256  
1:128  1:256  
1:256  1:256  
1:256  1:128  
1:128  1:256  
1:512  1:256  
1:256  1:256  
1:128  1:512  
1:256  1:128  
1:128  1:256  
1:256  1:256  
1:256  1:256  
Geomean IHA  
titres  
1.222.9  1:238.9  
  
4.8. IHA Titres of immunized Sheep  
The IHA antibodies titres of immunized sheep of group S1 were ranged from 1:128 to 
1:256 with a geomean titre was 1:194.0. Where as group S2 showed the titres ranged from1:128 
to 1:256 with a higher geomean titre was 1:207.9 as shown in table (18).   
Table .18.Results of IHA antibodies Titres of two groups of Sheep Immunized with  
 purified Fab adjuvanted.  
Group. No.  IHA antibody titres    Group. No.  IHA antibody titres  
  
         S1  
1:256    
          S2  
1:256  
1:128  1:256  
1:128  1:256  
1:256  1:256  
1:256  1:128  
Geomean IHA  
Titres  
1:194.0  1:207.9  
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4.9. Sterility and safety studies  
4.9.1. Sterility test  
All three vaccines, including OMPs anti-idiotype, OMPs  sub unit and plain bacterin, showed 
lack of turbidity in thiogllycolate broth and no sign of growth on the blood agar plate as 
observed up to 7 days of incubation. Meanwhile, inoculation remained negative for any 
anaerobic growth.  
4.9.2. Safety test for OMPs /anti-idiotypes vaccines  
Safety test of the vaccines (Plate 6) was evaluated in three groups of rabbits. Two ml 
of each vaccine was injected to each of the five rabbits and reaction was recorded for 7 days. 
No mortality indicated the safety of vaccines. All the rabbits showed normal body temperatures 
(101±0.3 °F to 103 ± 0.3°F) and recorded activities are detailed in table (19). However the 
rabbits remained healthy for 7 days post inoculation. The site of inoculation showed no 
inflammatory reaction except mild oedematous swelling which was resolved by 48 hours after 
inoculation.  
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Plate 6.  Pasteurella multocida B: 2 OPMs sub unit and anti-idiotype vaccines.  
  
Table.19. Safety test Activities of vaccinated Rabbits up to 7 days post injection.  
Type of 
vaccine  
Post 
vaccination  
Hours  
                                      Observations    
Local 
inflammation  
Body 
temperature  
Food 
intake  
Water 
intake  
Change in 
weight  
Plain 
bacterin  
24  Present  102.92 ± 0.86  Droped  Droped  Reduced  
48  Resolved  103.25± 4.0  Droped  Droped  Reduced  
72  -  102.25± 3.0  Normal  Normal  Normal  
96  -  101.90 ±0.35  Normal  Normal  Normal  
120  -  101.78 ±0.39  Normal  Normal  Normal  
144  -  101.54 ±0.35  Normal  Normal  Normal  
168  -  101.30 ±0.22  Normal  Normal  Normal  
OMPs   24    -  101.80 ±0.55  Droped  Droped  Reduced  
48  -  101.90 ±0.50  Normal  Normal  Normal  
72  -  101.98 ±0.25  Normal  Normal  Normal  
96  -  101.70 ±0.35  Normal  Normal  Normal  
120  -  101.65 ±0.30  Normal  Normal  Normal  
144  -  101.50 ±0.25  Normal  Normal  Normal  
168  -  101.40 ±0.5  Normal  Normal  Normal  
Antiidiotype  
  
24  -  101.44 ±0.52  Droped  Droped  Normal  
48  -  101.68 ±0.51  Normal  Normal  Normal  
72    101.62 ±0.55  Normal  Normal  Normal  
96    101.56 ±0.35  Normal  Normal  Normal  
120    101.44 ±0.25  Normal  Normal  Normal  
144    101.40 ±0.15  Normal  Normal  Normal  
168    101.36 ±0.55  Normal  Normal  Normal  
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4.10. Immune response of bacterin, OMPs and anti-idiotype vaccinated animals  
 4.10.1. Immune response of bacterin in buffaloes     
The buffaloes in group B1 showed the variable IHA antibody titres ranging from1:8 to 1:32, 
with GMT 14.9 at 10 days post inoculation and then increased IHA antibody titres with a range 
of 1:16-1:64, and GMT 48.5 at 40 days post vaccination, similarly the titres rose highest and 
had a range of 1:32 to 1:64 and highest GMT 59.7 at 70 days post vaccination. Meanwhile  
these titres started to decline ranging from1:16 to 1:32 and with GMT antibody titres 27.9 at 
100 days post vaccination and then continued to decreasing of these titres and it was ranged  
from 1:8 to 1:32 while GMT antibody titre was 17.1 at 130 days post vaccination. The same 
trend of declining was also observed with IHA antibody titres exhibited a range of 1:8 to 1:32 
with a decreased GMT antibody titre 14.9 at 160 days post vaccination. However the animals 
showed lowering titres which ranged from 1:4 to 1:16 with declined GMT 5.3 at 190 days post 
vaccination .The similar trend of immune response of the buffaloes still remained to low with 
range of IHA titres of 1:4 to 1:8 and presented poor GMT 4.0 at 220 days post vaccinat ion. 
Eventually the lowest antibody titres with values of 1:4 were observed with lowest GMT 2.1 
at 250 days post vaccination. The lowest IHA antibody titres were also examined as 1:4 and 
GMT antibody titre was 2.1 at 280 days post vaccination. The similar findings were seen with 
a titre of 1:4 had a GMT 2.1 at 310 days post vaccination. Such type of IHA antibody titre was 
detecded as 1:4 and GMT 0.0 at 340 days post vaccination and IHA antibody titre was not 
detected at 370 days post vaccination in the animals injected bacterin results are presented in 
tables (20, 27).  
4.10.2. Immune response of OMPs vaccine in buffaloes-   
 The buffaloes vaccinated with OMPs (group B 2) showed slow response with IHA antibody 
titres ranging from 1:8 to 1:32 and with GMT 13.0 at 10 days post vaccination and then started 
to increase, presented titres which were ranging from1:32 to 1:256 and indicated an up rise at 
initial stages with the GMT 90.5 at 40 days post vaccination. Similarly, it was observed  higher 
range of titres 1:64 to 1:256 and GMT 114.4 at 70 days post vaccination. However, it produced 
peak titers showing antibodies levels from1:64 to 1:512 with highest GMT 137.2 at 100 days 
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post vaccination. Then it was originated to decline with a range of titres from 1:32 to 1:128 
and lowering GMT 78.8 at 130 days post vaccination. While the  Table. 20. Serum antibody 
titres of Buffaloes group B1 immunized against Pasteurella multocida B: 2 bacterin.  
Group 
B1  
  
                              Post vaccinations days  
  
      
  
10  
  
40  
  
70  
  
100  
  
130  
  
160  
  
  
190  
  
220  
  
250  
  
280  
  
310  
  
340  
  
370  
IHA  
Antibody  
Titres  
1:16  1:64  1:64  1:16  1:32  1:16  
  
1:4  1:4  1:4  -  1:4  -  -  
1:8  1:64  1:64  1:32  1:16  1:8  
  
1:4  1:4  -  1:4  -  1:4  -  
1:8  1:64  1:64  1:32  1:16  1:16  
  
-  -  -  -  -  -  -  
1:16  1:32  1:64  1:32  1:16  1:32  
  
-  -  -  -  -  -  -  
1:16  1:64  1:64  1:16  1:8  1:8  
  
-  -  -  -  -  -  -  
1:16  1:16  1:64  1:32  1:16  1:16  
  
1:4  1:8  1:4  -  -  -  -  
1:32  1:32  1:64  1:32  1:16  1:16  
  
1:8  1:4  -  1:4  1.4  1:4  -  
1:16  1:64  1:32  1:32  1:16  1:32  
  
1:4  1:8  1:4  1:4  1:4  -  -  
1:16  1:64  1:64  1:32  1:32  1:16  
  
1:16  -  -  1:4  -  -  -  
1:16  1:64  1:64  1:32  1:16  1:8  
  
1:4  1:4  1:4  -  1:4  -  -  
  
declining tendency showed antibody titres which were ranged from 1:32 to 1:128 and GMT 
was 73.5 at 160 days post vaccination. Tremendously, the immune response was investigated 
with lowering titres which ranged from 1:32 to 1:64 and GMT was 48.5 at 220 days post 
vaccination. The OMPs vaccine persuaded IHA antibody titres ranged from 1:8 to 1:64 and 
showed a gradual decrease with GMT 32.0 at 250 days post vaccination. Where as an antibody 
titres were observed with a range from1:16 to 1:32 and presented a GMT 21.1 at 280 days post 
vaccination. The decreasing trend of antibody titres was sustained with a range from1:8 to1:32 
66  
  
and GMT 17.1 at 310 days post vaccination. The immune response was reached with a further 
turn down in antibody titres and ranged from 1:4 to1:16 and lowered  
GMT was 9.8 at 340 days post vaccination. Eventually the antibody titre was evident minimum 
as 1:4 and produced a lowest GMT 4.0 at 370 days post vaccination presented in tables (21, 
27).  
Table.21. Serum antibody titres of Buffaloes group B2 Immunized against Pasteurella 
multocida B: 2 OMPs Sub unit vaccines.  
Group  
B2  
  
                                                   Post vaccinations days   
     
  
10  
  
40  
  
70  
  
100  
  
130  
  
160  
  
  
190  
  
220  
  
250  
  
280  
  
310  
  
340  
  
370  
IHA  
Antibody  
Titres  
1:8  
  
1:32  1:64  1:128  1:128  1:128  1:64  1:32  1:32  1:16  1:8  1:16  1:4  
1:16  
  
1:64  1:64  1:512  1:64  1:32  1:64  1:64  1:16  1:32  1:16  1:8  1:4  
1:8  
  
1:128  1:256  1:64  1:128  1:128  1:32  1:64  1:32  1:32  1:16  1:16  -  
1:16  
  
1:64  1:64  1:128  1:64  1:32  1:64  1:64  1:64  1:16  1:32  1:4  1:4  
1:16  
  
1:256  1:128  1:128  1:128  1:64  -  -  -  -  -  -  -  
1:32  
  
1:128  1:256  1:64  1:64  1:128  1:64  1:64  1:32  1:16  1:16  1:8  1:4  
1:16  
  
1:32  1:256  1:512  1:128  1:64  1:32  1:64  1:64  1:32  1:32  1:16  1:4  
1:8  
  
1:64  1:128  1:64  1:128  1:128  1:64  1:32  1:16  1:32  1:16  1:4  1:4  
1:32  
  
1:256  1:64  1:256  1:32  1:64  1:64  1:64  1:32  1:16  1:32  1:16  1:4  
1:8  
  
1:128  1:64  1:64  1:32  1:64  1:64  1:32  1:32  1:16  1:8  1:16  1:4  
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4.10.3. Immune response of anti-idiotype vaccine in buffaloes   
The immune response of anti-idiotypes vaccine in buffaloes (group B 3) induced the IHA 
antibody titres initially ranging from 1:8 to1:32 and GMT 18.4 at 10 days post vaccinat ion. 
The results are presented in tables (22, 27). Then it started to increase in the titres with a range 
from 1:32 to 1:256 and GMT 90.5 at 40 days post vaccination. The IHA antibody titres were 
recorded with the phase of uprising which ranged from1:64 to1:256 and produced GMT  
119.0 at 70 days post vaccination. Similarly, the antibody   
Table.22. Serum antibody titres of Buffaloes group B3 Immunized against Pasteurella 
multocida B: 2 OMPs Anti-idiotype vaccine.  
Group  
B3  
                               Post vaccinations days  
  
       
  
10  
  
40  
  
70  
  
100  
  
130  
  
160  
  
  
190  
  
220  
  
250  
  
280  
  
310  
  
340  
  
370  
IHA  
Antibody  
Titres  
1:16  
  
1:32  1:64  1:64  1:128  1:64  1:64  1:64  1:32  1:32  1:32  1:16  1:8  
1:8  
  
1:32  1:128  1:128  1:32  1:128  1:64  1:64  1:64  1:16  1:32  1:8  1:8  
1:32  
  
1:128  1:128  1:64  1:128  1:128  1:32  1:64  1:32  1:32  1:16  1:16  1:8  
1:16  
  
1:256  1:64  1:128  1:64  1:64  1:64  1:32  1:32  1:32  1:8  1:16  1:8  
1:16  
  
1:256  1:256  1:128  1:256  1:128  1:64  1:64  1:32  1:32  1:32  1:16  -  
1:32  
  
1:128  1:128  1:256  1:128  1:128  1:32  1:32  1:32  1:16  1:16  1:8  1:8  
1:16  
  
1:64  1:256  1:256  1:128  1:64  1:64  1:32  1:16  1:16  1:32  1:4  -  
1:32  
  
1:32  1:128  1:512  1:128  1:128  1:64  1:64  1:32  1:32  1:16  1:4  1:8  
1:16  
  
1:128  1:64  1:64  1:256  1:256  1:64  1:64  1:32  1:32  1:8  1:16  1:4  
1:16  
  
1:128  1:128  1:256  1:64  1:64  1:64  1:64  1:64  1:32  1:32  1:16  1:4  
  
response illustrated a peak titres ranging from 1:64 to1:512 and highest GMT 147.0 at 100 days 
post vaccination. For the meantime it was found to decline the antibody titres which were 
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ranged from 1:32 to 1:256 and GMT 111.4 at 130 days post vaccination. The decreased 
immune response was observed with titres ranging from 1:64 to 1:256 and GMT 104.0 at 160 
days post vaccination.  The antibody titre was declined gradually and proved the titres ranged 
from 1:32 to 1:64 and GMT 55.7 at 190 days post vaccination. The similar declining trend 
produced the antibody titres ranging from 1:32 to 1:64 and GMT 52.0 at 220 days post 
vaccination. The lowering of the titres still remained which was ranged from 1:16 to1:64 and 
presented GMT 34.3 at 250 days post vaccination. A further decrease was continued and 
recorded the titres ranging from 1:16 to 1:32 and GMT 26.0 at 280 days post vaccination. The  
poorer titres were detected ranging from 1:8 to 1:32 and GMT 19.7 at 310 days post 
vaccination. The antibody titres were also decreased ranging from1:4 to 1:16 and GMT 10.6 at 
340 days post vaccination. The minimum levels of antibody titres were observed with a range 
from1:4 to 1:8 and demonstrated lowest GMT 4.6 at 370 days post vaccination.   
4.10.4. Immune response of bacterin in cattle   
The immune response of bacterin was determined in cattle (group C1) and showed variable 
IHA antibody titres ranging from 1:4 to 1:32 and GMT 16.0 at 10 days post vaccination. A 
sudden rise was recorded which ranged from 1:8 to 1:64 and GMT 36.8 at 40 days post 
vaccination. The antibody titre showed a peak with a range from 1:32 to 1:128 and highest 
GMT 59.7 at 70 days post vaccination. Then titres started to decline gradually and had a range 
from 1:16 to 1:64 and GMT 32.0 at 100 days post vaccination. Similarly the immune response 
remained to decrease and the titres ranged from 1:8 to1:32 and GMT 17.1 at 130 days post 
vaccination. The declining trend of antibody titres was also observed and produced a range of 
titres from 1:8 to 1:32 and GMT 13.0 at 160 days post vaccination. The antibody titre more 
lowered down had a range from 1:4 to 1:16 and GMT 5.7 at 190 days post. The decreased titres 
presented a range from 1:4 to1:8, and GMT 4.3 at 220 days post vaccination. The levels of 
antibodies did not respond further values than1:4 and had a lowered GMT 2.6 at 250 days post 
vaccination. Similar declined titres were also investigated with values 1:4 and lowest GMT 1.0 
at 280 and 310 days post vaccination. The antibody levels were detected with a titre 1:4 and 
GMT 0 at 340 days post vaccination. IHA titre was undetectable at 370 days post vaccinat ion 
the results are shown in tables (23, 27).  
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Table. 23. Serum antibody titres of Cattle group C1 Immunized against Pasteurella 
multocida B: 2 bacterin  
Group  
C1  
                               Post vaccinations days  
  
      
IHA  
Antibody  
Titres  
10  
  
40  70  100  130  160  190  220  250  280  310  340  370  
1:16  
  
1:64  1:64  1:16  1:32  1:16  1:4  1:4  1:4  1:4  1:4  -  -  
1:8  
  
1:32  1:64  1:32  1:16  1:8  1:8  1:4  -  -  -  -  -  
1:4  
  
1:+64  1:128  1:32  1:16  1:8  -  -  -  -  -  -  -  
1:16  
  
1:32  1:64  1:32  1:16  1:32  1:4  -  -  -  -  1:4  -  
1:32  
  
1:64  1:32  1:64  1:8  1:8  -  -  -  -  -  -  -  
1:16  
  
1:16  1:64  1:32  1:16  1:16  1:4  1:8  1:4  -  1:4  1:4  -  
1:32  
  
1:32  1:64  1:32  1:16  1:16  1:8  1:4  1:4  1:4  1:4  -  -  
1:16  
  
1:64  1:32  1:32  1:16  1:32  1:4  1:4  -  1:4    -  -  
1:32  
  
1:8  1:64  1:32  1:32  1:8  1:16  1:4  1:4  -  -  -  -  
70  
  
1:16  1:64  
  
  
1:64  1:32  1:16  1:8  1:4  1:4  1:4  -  -  -  -  
  
4.10.5. Immune response of OMPs vaccine in cattle   
 The cattle vaccinated with OPMs subunit vaccine (Group C2) provoked the better immune 
response and produced IHA antibody titres ranging from 1:8 to 1:32 initially and GMT 14.9 at 
10 days post vaccination. Then the titre showed an up rise and ranged from 1:32 to 1:256 and 
with increased GMT 78.8 at 40 days post vaccination. The antibody titres were continued to 
increase and found a range from 1:64 to 1:256 and GMT 104.0 at 70 days post vaccinat ion. 
However, it attained a peak levels had a range from 1:64 to 1:512 and demonstrated a highest 
GMT 119.4 at 100 days post vaccination. Meanwhile it was found that the immune response 
was towards declining phase and titres were 1:64 to 1:128 and GMT 84.4 at 130 days post 
vaccination. The titres were determined with a range from 1:16 to 1:128, indicated a regular 
decrease of antibodies and resulted in GMT 73.5 at 160 days post vaccination. The antibody 
titres were still decreasing rapidly which ranged from 1:32 to 1:64 and GMT 45.3 at 190 days 
post vaccination. Similar finding of decreasing trend was also observed and ranging from 1:16 
to 1:64 and produced GMT 39.4 at 220 days post vaccination. The titres exhibited a range from 
1:16 to 1:64 which responded the declining trend and recorded GMT 34.3 at 250 days post 
vaccination. IHA titres were continuously decreasing and showed a range from1:8 to 1:32 and 
GMT 19.7 at 280 days post vaccination. Further declining of antibody titres was recorded from 
1:4 to 1:32 and GMT 13.9 at 310 days post vaccination. The titres were observed with a range 
from 1:4 to 1:16 which is another indication of lowering the antibodies and  GMT 9.2 was at 
340 days post vaccination. Ultimately the minimum levels of antibodies reached at a range 
from1:4 to 1:8 and had lowest GMT 4.3 at 370 days post vaccination results are presented in 
tables (24, 27).   
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Table. 24. Serum antibody titres of Cattle group C2 Immunized against Pasteurella 
multocida B: 2 OMPs Sub unit vaccines.  
Group   
C2  
  
                                                        Post vaccinations days   
     
  
10  
  
40  
  
70  
  
100  
  
130  
  
160  
  
  
190  
  
220  
  
250  
  
280  
  
310  
  
340  
  
370  
IHA  
Antibody  
Titres  
1:8  
  
1:128  1:64  1:128  1:128  1:128  1:64  1:16  1:32  1:16  1:16  1:16  1:4  
1:16  
  
1:32  1:64  1:64  1:64  1:64  1:32  1:64  1:16  1:32  1:32  1:16  1:4  
1:8  
  
1:64  1:64  1:128  1:128  1:128  1:32  1:64  1:32  1:32  1:16  1:16  1.4  
1:16  
  
1:64  1:64  1:64  1:64  1:128  1:64  1:32  1:64  1:16  1:16  1:8  1:4  
1:16  
  
1:32  1:128  1:128  1:128  1:128  1:32  1:16  1:64  1:32  1:8  1:4  1:4  
1:32  
  
1:128  1:256  1:64  1:64  1:32  1:64  1:64  1:16  1:16  1:4  1:8  1:8  
1:32  
  
1:64  1:256  1:256  1:128  1:64  1:32  1:64  1:64  1:32  1:16  1:4  -  
1:8  
  
1:64  1:128  1:64  1:64  1:64  1:64  1:32  1:16  1:16  1:32  1:16  1:4  
1:16  
  
1:128  1:128  1:512  1:64  1:128  1:64  1:64  1:64  1:8  1:16  1:8  1:4  
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1:16  
  
1:256  1:64  1:128  1:64  1:16  -  -  -  -  -  -  -  
  
  
  
  
  
  
4.10.6. Immune response of anti-idiotype vaccine in cattle   
The immune response of anti-idiotype vaccine in cattle (group C3) produced better results 
comparatively, and showed the IHA antibody titres at first, ranging from1:8 to 1:32 and GMT 
17.1 at 10 days post vaccination. Then it was determined an increase of antibody titres and 
exhibited the titres which ranged from 1:32 to 1:256 and GMT 84.4 at 40 days post vaccinat ion. 
The antigenic response was extremely increasing and titres had a range from 1:64 to 1:512 and 
higher GMT 114.4 was observed at 70 days post vaccination. These titres attained a maximum 
level which ranged from 1:64 to 1:512 and reached a highest value of GMT 137.2 at 100 days 
post vaccination. Suddenly the antibody titres found to decline had a range from1:32 to 1:256 
and GMT 97.0 at 130 days post vaccination. Similarly the declining stage was recorded and 
ranged from 1:32 to 1:256 and GMT 90.5.0 at 160 days post vaccination. A gradual decrease 
in antibody titres was determined with a range from 1:32 to 1:64 and GMT 48.5 at 190 days 
post vaccination. Another decrease was continued and titres were ranged from 1:16 to 1:64 and 
GMT 39.4 at 220 days post vaccination. The antibody titres were detected continuous ly 
decreasing with a range from .1:16 to 1:64 and GMT 36.8 at 250 days post vaccination. The 
titres still remained to towards lowe levels with a range from 1:16 to 1:64 and GMT 26.0 at 
280 days post vaccination. The declining phase of the titres produced a range from 1:8 to 1:32 
and GMT 21.1 at 310 days post vaccination. In the meantime it continued to decrease and had 
a range from 1:4 to 1:32 with GMT 16.0 at 340 days post vaccination. Finally the minimum 
antibody titres were investigated with a range from1:4 to1:8 and created a lowest GMT 4.9 at 
370 days post vaccination as the results are presented in tables (25, 27).  
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Table.25.Serum antibody titres of Cattle group C3 Immunized against Pasteurella   
multocida B: 2 OMPs Anti-idiotype vaccines.  
 Group  
 C3  
  
                                              Post vaccinations days   
     
  
10  
  
40  
  
70  
  
100  
  
130  
  
160  
  
  
190  
  
220  
  
250  
  
280  
  
310  
  
340  
  
370  
IHA  
Antibody  
Titres  
1:16  
  
1:32  
  
1:64  1:128  1:64  1:128  1:64  1:64  1:32  1:64  1:32  1:16  1:4  
1:16  
  
1:64  
  
1:256  1:256  1:128  1:64  1:64  1:32  1:32  1:16  1:16  1:32  1:4  
1:32  
  
1:128  
  
1:512  1:64  1:32  1:128  1:32  1:64  1:64  1:32  1:32  1:32  -  
1:8  
  
1:32  
  
1:64  1:128  1:64  1:64  1:32  1:16  1:32  1:32  1:16  1:16  1:8  
1:16  
  
1:256  
  
1:128  1:256  1:128  1:64  1:64  1:64  1:16  1:32  1:32  1:16  1:4  
1:32  
  
1:128  
  
1:128  1:64  1:64  1:128  1:32  1:64  1:32  1:16  1:32  1:8  1:8  
1:8  
  
1:16  
  
1:64  1:512  1:128  1:32  1:32  1:32  1:64  1:16  1:8  1:32  -  
1:16  
  
1:128  
  
1:64  1:64  1:128  1:256  1:64  1:32  1:32  1:32  1:32  1:16  1:8  
1:32  
  
1:256  
  
1:64  1:256  1:256  1:128  1:64  1:64  1:32  1:16  1:16  1:4  1:4  
1:16  
  
1:128  
  
1:128  1:64  1:128  1:64  1:64  1:16  1:64  1:32  1:16  1:16  1:4  
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4.11. Results of challenge/protection test  
All six immunized groups with bacterin, OMPs and anti-idiotypes vaccines of buffaloes and 
cattle (three in each group) showed variable level of protection which was well differentiated. 
The group B1 and C1 immunized animals with bacterin exhibited morbidity within 24 hours 
post-inoculation. The heart blood was cultured in BHI broth, as examined with Giemsa’s stain 
and confirmed the presence of P. multocida typical bi-polar appearance under the microscope. 
There was complete protection (P < 0.001) in animals immunized with antiidiotype vaccine 
followed by 67 % protection against OMPs sub-unit vaccine and no protection was observed 
in animals immunized with the plain bacterin group results are shown in table (26).  
Table.26. Results of Challenge/ Protection test against Pasteurella multocida B: 2 Applied 
at 160 days post vaccination.  
Groupsof 
vaccinates  
No.of  animals 
challenged  
Morbidity  Survival  Percentage 
protection  
B1  3  
  
3  0/3  0  
B2  
  
3  1  2/3  67  
B3  
  
3  0  3/3  100  
C1  
  
3  3  0/3  0  
C2  
  
3  1  2/3  67  
C3  
  
3  0  3/3  100  
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Table:27.  Geometric mean Titres / Cumulative mean Titres of Buffaloes and Cattle  
groups.  
Sampling 
post 
vaccination 
days  
  
                                        Groups of Animals  
  
B1  B2  B3  C1  C2  C3  
10  14.9  
  
13.0  18.4  16.0  14.9  17.1  
40  48.5  
  
90.5  90.5  36.8  78.8  84.4  
70  59.7  
  
114.4  119.4  59.7  104.0  111.4  
100  27.9  
  
137.2  147.0  32.0  119.4  137.2  
130  17.1  
  
78.8  111.4  17.1  84.4  97.0  
160  14.9  
  
73.5  104.0  13.0  73.5  90.5  
190  5.3  
  
52.0  55.7  5.7  45.3  48.3  
220  4.0  
  
48.5  52.0  4.3  39.4  39.4  
250  2.1  
  
32  34.3  2.6  34.3  36.8  
280  2.1  
  
21.1  26.0  1.0  19.7  26.0  
310  2.1  
  
17.1  19.7  1.0  13.9  21.1  
340  0  
  
9.8  10.6  0  9.2  16.0  
370  0  
  
4.0  4.6  0  4.3  4.9  
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Cumulative   
means  
titres  
  
15.27  
  
53.22  
           
61.04            
             
14.55  
             
49.31  
  
56.40  
  
  
  
  
4.11.1. Examination of the challenged/ morbid animals   
The examination of the challenged calves were performed regarding the signs of 
bronchopneumonia, lymphadenitis and fever in all (eighteen) calves up to 24 hours post 
challenge. These were also examined for any kind of odematous swelling on head neck and 
throat. The morbid calves were treated with antibiotics and non steroids drugs, which were 
recovered after 24 hours  
4.11.2. Disposal of the carcasses  
According to the University of Agriculture Faisalabad (UAF) Lab Safety Rules 
Committee all the slaughtered rabbits and infected carcases during the experiment were 
wrapped in polyethylene bags (locked properly) and sprayed with formalin and processed for 
incineration.  
77  
  
 
Fig.1.Comparative indirect haemagglutination antibody titres (GMT) in vaccinated 
groups of buffaloes.  
 
Fig.2.Comparative indirect haemagglutination antibody titres (GMT) in vaccinated 
groups of cattle.  
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Fig. 3.Comparison of cumulative indirect haemagglutination antibody means titres in  
vaccinated groups of buffaloes.  
  
 
Fig.4 .Comparison of cumulative indirect haemagglutination antibody means titres in 
vaccinated groups of cattle.  
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CHAPTER V    DISCUSSION  
The present research was designed to understand the prevalence percentage of HS in cattle and 
buffaloes of districts Chiniot and Faisalabad in relation to agro-climatic conditions with 
isolation and characterization of Pasteurella multocida from suspected cases of field outbreaks. 
To study the incidence of disease, the samples were collected from July to August 2011 and 
data was analyzed, evaluated and reported for examining epidemiological pattern and seasonal 
trends for occurrence of the disease. The purpose of this experiment was to generate OMPs 
anti-idiotype vaccine and evaluation of OMPs sub-unit vaccine as well as  plain bacterin which 
are intelligible enough to be analyzed for evaluation and priority for expansion of mass 
vaccination work and to introduce reliable efficacious vaccine in the country based on the data.  
5.1. Prevalence percentage of HS  
The percentage prevalence of HS in the districts of Chiniot and Faisalabad under study 
period was recorded as 2.5% and 1.20% respectively. This is related to the studies accordingly 
as reported 0.80% prevalence in Faisalabad (Durani et al., 2013.)  Whereas in another study it 
was recorded highest in district Khanewal as 49% while highest importance was 75.64% in 
district Faisalabad (Farooq et al., 2007). There is an obvious variation in incidence of 
haemorrhagic septicaemia outbreaks in the various countries involving different types of 
animals as claimed by De Alwis, (1999). The outbreaks of HS infection happen right through 
the year regardless of the rainy weather as reported by Kumar et al., (2004).  
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 5.2. In vitro antibiotic susceptibility of P. multocida isolates  
The bacterial organisms over a period of time change their antibiogram patterns and 
develop resistance against commonly used chemotherapeutic agents. Thus during this study in 
vitro antibiotic susceptibility of the isolates was carried out which can help for proper and 
effective treatment. In the present study eight P. multocida isolates were tested for their 
antibiotic sensitivity pattern against ten commonly used antibiotics (Table 15). During study 
all the isolates (100%) were found to be sensitive to Florfenicol and Cephalexin followed by 
Tetracycline, Ampicillin and Nitrofurantoin each 50 percent. All  the isolates (100%) were 
resistant to Penicillin (Table16).  
Resistance to antibiotics in HS strains of P. multocida has not been a major problem. 
Thus, of the antibacterial compounds that are recommended for use in cattle and buffaloes, that 
can be conveniently appear to be most useful, but the sensitivity patterns, however, are likely 
to vary from one country to another depending on the prevailing drug usage practices, a 
knowledge of the sensitivity patterns of local strains will be useful in deciding the drug of 
choice.  
HS is an important fascinating disease and theoretically, could be treated effectively by 
the wide range of antibiotics currently available. As a matter of fact however, treatment is 
constrained by a host of practical considerations. It has been investigated that the infected 
animals can be cured only if they have been treated in the very early stages of the disease (OIE, 
2009). The conditions for an early diagnosis of the disease and hence its effective treatment are 
usually lacking in primitive husbandry systems in the developing countries. Various strains of 
Pasteurella multocida differ in terms of vulnerability to different antibiotics. Majority of the 
Pasteurella multocida isolates established resistance to various sulpha drugs with variable 
sensitivity to Gentamicin, Penicillin-G, Streptomycin, Sulphonamides and Trimethoprim were 
assessed by performing disc diffusion method as detailed by De Alwis, (1999) and 
Shivachandra et al., (2004). It has been identified that the conjugative R-plasmids were 
considered for inter-species and intergenic increase of multiple drug resistance, and also among 
the pathogenic strains the transfer of such plasmids may lead to a rise in the epidemic spread 
of disease as observed by Stone, (1975). In reality, the injudicious and frequent use of 
antibiotics is ultimately promoting to antibiotic resistance in many developing countries, the 
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responsible responding genes may be present on the Rplasmids demonstrated by Hirsh et al., 
(1981).  
A number of Pasteurella multocida plasmids have been detected that carry mult ip le 
resistance genes. The plasmid pVM111, isolated from a fowl cholera causing strain, carries 
genes for Sulphonamide, Streptomycin and Tetracycline resistance (Kehrenberg et al., 2003). 
However, recently, irregularities have been noticed in the antibiotic sensitivity of P. multocidas 
reported by Biswas et al., (2004) and Kumar et al., (2004, 2009). The findings of the scientis ts 
have been elaborated that the reason for this futile therapy is due to the emergent multi-drug 
resistant strains, and these strains have emerged due to increased use of antibiotics with the 
role of supplement in different feeds, as control measures or growth promoter, for 
subtherapeutic use in the animal rations. A study was conducted regarding the drug resistance 
and a rise in the number of multiple drug-resistant (MDR) strains of Pasteurella multocida was 
observed by Biswas et al., (2004) particularly for Sulphadiazine, which was considered as the  
medicine of choice to control HS in the field cases, as well as many other typically used 
antibiotics such as Penicillin, Amikacin, Erythromycin and Carbencillin, where there is a slow 
progress of resistance as detected by Kumar et al., (2009). Numerous isolates with R-plasmids 
approved resistance genes to antibiotics as reported Chloramphenicol Streptomycin, 
Kanamycin, Sulphonomides, Tetracycline, and Penicillin (ROB-1 β lactamase gene), thus 
convening considerable resistance to chemotherapuetic agents as studied by Silver et al., 
(1979).   
Recently it has been proved that some antibiotic resistant P. multocida strains carry 
multiple plasmids, each with one or two antibiotic resistance genes (San Millan et al., 2009). 
While during the experiment, it was studied that Ampicillin resistant and multiple antibiot ic 
resistant P. multocida isolates from pigs, a range of highly related plasmids was identified, 
pB1000 which was a ColE1-type plasmid, 4613 bp in length and carried the Ampicil lin 
resistance gene blaROB-1, pB1005 encoding Streptomycin and Sulphonamide resistance and 
pB1006, pB1001 and p9956 that carried the Tetracycline resistance genes tet (O), tet (B) or tet 
(H), respectively. Some strains had more than one of these plasmids; Ampicillin, Streptomycin 
and Sulphonamide resistant strains generally had both pB1000 and pB1005, whereas some 
Ampicillin, Streptomycin, Sulphonamide and Tetracycline resistant strains had pB1000, 
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pB1005 and pB1006. The plasmids all contained highly related mobilisation and oriV regions. 
The oriV region is considered to be responsible for plasmid replication and copy number 
control. Moreover the oriV regions of the different plasmids were closely related, they were 
not identical; it is assumed that these differences are sufficient to allow stable coexistence of 
up to at least three of these plasmids in the same cell (San Millan et al., 2009).  
  
  
5.3 Characterization of outer membrane protein (OMPs) profiles  
The present study provides valuable information about the protein profile and 
molecular profile of six isolates of P. multocida obtained from buffaloes and a standard strain 
PM 2004.   
5.3.1. Characterization of Protein bands from P. multocida isolates  
It has been observed that these OMPs are immunogenic in nature and the antibodies 
produced in response to them exhibit a very potent protective sort of activity, these antigens 
can be used as valuable components in the formation of subunit vaccines (Confer et al., 2001). 
Protein band patterns during SDS-PAGE can serve as a guide towards effective vaccine 
developments. Amongest the reported proteins which have been identified by their band 
patterns. The relationships between electrophoretic pattern and serotype properties of isolates 
have been observed (wheeler, 2009). One of the most identified proteins is the P. multocida 
toxin which has been fully characterized; it is a monomeric protein with the Nterminal region 
containing the binding and translocation domain that directs to its endocytosis investigated by 
Baldwin et al., (2004).  
Presently, the few proteins of outer membrane of Pasteurella multocida, together with 
OmpA, Oma78, OmpH, PlpB, GlpQ, Lpp and P6 like protein have been characterized 
experimentally regarding immunogenicity and their structure; recently different proteomic 
studies exposed the presence of 28 other proteins and out of these 10 are porins as detailed by 
Boyce et al., (2006). Many OMPs have been determined as virulence factors; out of these 
OMPs the OmpH is considered the most effective. It was seen to be exist in all the bovine 
isolates determined by Dabo et al., (2007) and is when used as a potential immunogen as it 
protected mice and chicken against Pasteurella multocida challenge, detected in experiments 
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by Luo et al., (1999), Vasfi Marandi and Mittal, (1997). OmpH is also known as Protein H and 
is a trimeric porin, having a molecular weight of 37.5 KDa found by Chevalier et al., (1992). 
Till now it is the only porin that has been experimented on to check its capacity to activate 
immune cells. To date more than 60 different outer membrane proteins (OMP) of different 
strains have been reported to play a role in pathogenesis and induction of immunity (Hatfalud i 
et al., 2010).  
It has been reported in another study that seven polypeptide bands having different 
molecular weights obtained from P.multocida, the protein ranged from 36.31 KDa to 104.71 
KDa. The results also exhibited that all the isolates were from the similar serotype; the 51.29 
and 36.31 KDa fractions were thick and were accepted as the prominent protein fractions of  
P. multocida whole strain protein. Meanwhile other bands obtained were 60.26, 69.18, 77.62, 
85.11, and 104.71 KDa (Numan et al., 2008). But according to Sridevi et al., (1999), 13 bands 
were obtained from P. multocida entire cell by the SDS-PAGE technique amongst the 61.27 
KDa and 26 KDa bands were most prominent. Furthermore another study have reported 5 
bands from P. multocida, the bands were 27, 32, 35, 37 and 44 KDa studied by Johnson et al., 
(1989). However studies with different strains of P. multocida by Lee et al., (1991) suggested 
that there were no band patterns which were serotype specific as concerned to protein moieties 
of avian isolates analyzed by SDS-PAGE. There are several other works done on protein 
pattern from P. multocida that contributes towards identifying a candidate protein and may 
guides to cloning the gene that encodes the protein. Dabo et al., (1997) through SDS-PAGE, 
two main fractions of 35 KDa and 46 KDa molecular mass of bovine P. multocida separated 
from cattle and pig sources. (Pati et al., 1996) also analyzed ten protein bands having molecular 
mass of 88 KDa to 25 KDa, amongst these 44.37 KDa and30 KDa bands were considered as 
major immunogens. Eight protein bands (94, 84, 53.5, 49, 43, 41, 29.5 and 16 KDa) on SDS-
Page analysis have been reported (Morton et al., 1996). The protein band of molecular weight 
4KDa was found in all serovars. More than a few other experiments  described by various 
workers as Ireland et al., (1991), Lee et al., (1991), Syuto & Matsumoto, (1982) recommended 
that the number of  carbohydrate  and protein bands analyzed by SDS-PAGE, differed from 
one experiment to another and the reason may be type and strain of the antigen. Studying these 
proteins and their band formations as well as comparative analysis may therefore open a new 
way towards modern vaccineology especially with announcement of more whole genome 
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sequence of P. multocida. It is more than 10 years now since the establishment of more genome 
sequence result of Pasteurella multocida explained by May et al., (2001) however; most of 
these proteins remain uncharacterized (Boyce et al., 2012).  
   
  
5. 4. Comparative evaluation of immune response of experimental trailed vaccines  
This research work was planned with an other objective to prepare, evaluate and 
compare HS alum precipitated vaccine, OMPs sub-unit and anti-idiotype vaccine. The 
Montanide added vaccine has a better and stronger immunogenic activity than the alum 
precipitated bacterin, owing to its retention in the tissue as a depot for longer period thus, 
providing a prolonged antigenic stimulus for antibody formation.  
5 .4. 1. Immune response of bacterin in buffaloes versus cattle  
The vaccination with bacterin induced immune response was studied in groups B1 and 
C1. The antibody titre initially was lower in buffaloes than cattle at 10 days post vaccinat ion. 
Where as the titre was higher in buffaloes with values GMT 48.5 than cattle was 36.8 at 40 
days post vaccination.While the titre was recorded equally at 70 days post vaccination and it 
was the highest titres (Fig. 1, 2 and Table 27) observed in bacterin vaccinated animals. The 
antibody titre was started to decline at 100 days post vaccination. The declining phase was 
continued enormously till 370 days post vaccination. However the GMT antbody titre was not 
considered valueable at 160 days post vaccination because of it did not produced any challenge 
protection in both groups (Table 26 ).  
It indicates that immune response of killed antigen vaccines which follows a single 
inoculation of a dead antigen usually falls to a negligible level within a few weeks. It can be 
rapidly revived at this time by secondary or booster dose, usually of about the same quantity 
of antigen as given in the primary inoculation. By employing killed vaccines adminsterd in 
haemorrhagic septicaemia affected areas and to lessen incidence of the disease have been 
reported by these vaccinations (OIE, 2009), but immunity is short lived, outbreaks still reported 
as described  by Benkirane and De Alwis, (2002)  and Biaswas et al., (2004).   
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In all countries where disease incidence is higher, vaccination is believed to be 
successful means of controlling the disease prophylactically (Bain et al., 1982, De Alwis, 1996 
and Mathy et al., 2002). The control of haemorrhagic septicaemia continues a problem since 
conventional vaccines are not adequately effective and require repeated injections. However, 
in the recent years, the vaccination of calves with inactived P. multocida through aerosol and 
intratracheal resulted in very less protection against experimentally induced respiratory 
challenge observed by Confer et al., (1996) and Prado et al., (2005). To use live strains as 
suitable vaccines, the attenuation mode should be clear and developed in such a way that there 
should be less chances of reversion to virulence .Using live vaccines the improved resistance 
to respiratory P. multocida challenge has been confirmed in some research. These include 
chemically modified P. multocida, wild-type bacteria, mutants which are Streptomycin 
dependent investigated by Confer et al., (1996) and Mathy et al., (2005).  
HS is a primary pasteurellosis recoginzed by an acute extremely fatal septicemia and is 
distinct from other pasteurellosis with high morbidity and mortality, in which Pasteurella 
multocida may play only a secondary role. The virulence factors such as lipopolysaccharides, 
adhesins and OMPs of Pasteurella multocida liable for the cause of haemorrhagic septicaemia 
have not been identified, and there is very less information about the immunogens responsible 
for the natural immune response against them. Control of HS is achieved to some level, when 
alum adsorbed bacterin or oil-adjuvanted killed whole-cell vaccines are given, but these 
vaccines only induced antibodies for a short time. (Chandrasekaran et al., 1994 ) and 
necessitated annual administration for effectiveness of these bacterins (De Alwis, 1992). A 
disadvantage of high viscosity is achieved when the oiladjuvanted vaccines are put to use, 
making them unpopular for administration, however improved lower viscosity possessing oil-
adjuvanted vaccines have been explained (Shah et al., 1997 and Verma and Jaiswal 1997, 
1998). Ultimately, such type of vaccines require high inactivated cells (1010 - 1011) in numbers 
and reactogenicity is a major concern when they are used.  
  Naturally acquired immune response is common among survivors of haemorrhagic 
septicaemia outbreaks, and as a result, animals up to 2 years old are most at risk. There is little 
knowledge baout the location and multiplication organism during the early clinical stage of the 
HS disease, Even though rapid translocation of bacteria is involed in the HS pathogenesis from 
86  
  
the respiratory tract towards the blood and lymph. In various attempts to mimic the natural 
infection and to lead towards the development of long-term cellular and humoral immunity, 
live vaccines have been manufactured (Myint and Carter. 1989), but the safety of these 
vaccines is questionable.   
  
  
5.4. 2. Immune reponse of OMPs sub-unit vaccine in buffaloes versus cattle  
The P. multocida OMPs vaccine showed variable results of immune response in both 
groups B2 and C2. The antibody titre firstly was lower in buffaloes than cattle at 10 days post 
vaccination. Then the titre was recorded higher in buffaloes with GMT 90.5 and in cattle was 
78.8 at 40 days post vaccination. Similarly, the titres were observed with higher values in 
buffaloes than cattle alongwith peak levels at 100 days post vaccination (Fig.1 and 2). The 
antibody titre was started to decline at 130 days post vaccination with higher titre in cattle than 
buffaloes. Where as the GMT antibodies presented equal results in both groups of the animals 
at 160 days post vaccination and exhibited 67% challenge protection (Table 26). Then 
declining trend was observed continously till 370 days post vaccination showing higher GMT 
antibody titres in buffaloes than cattle (Table 27).  
Studies were focused on putative immunologically important antigens and showed 
those antigens processed under in vivo conditions (Adleret al., 1999). These included OMP 
Oma87, which is actually a homologue of the D15 immunoprotective antigen of H influenza 
type 4 fimbria and its subunit protein PtfA capsule, and IROMPs such as the TbpTbpA. No 
research was done on these candidate vaccines reagarding the stimulation of immunity in cattle 
as a response to serotype A of P. multocida. Cloning and expression of the gene for Oma87 
has been done, though vaccination against that protein did not provide protection to chickens 
as an experimental challenge (Chaudhuri and Goswami, 2001 and Mitchison et al., 2000).  
Aminoterminus sequencing indicated about the heat modifiable nature of the 35 KDa 
protein (28, 35 KDa) OMP belonging to the family of proteins OmpA analysed by Dabo et al., 
(1970). But immunization of mice with the moderately purified protein did not provide any 
sort of protection against intraperitoneal P. multocida challenge observed by Gatto et al., 
(2002). An additional  OMP of Pasteurella multocida having the ability to stimulate immunity 
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to diseased animals is OmpH, about 33.6, 38.5 KDa protein observed by Davies and Lee, 
(2004) and Vasafi and Mittal, (1997). That protein however, has not been identified 
immunologically in cattle. Important antigens liable for antibodies against Pasteurella 
multocida B: 2 serotype  isolates of cattle and buffalo, with respect to HS, are not completely 
understood. Outer membrane proteins are considered to be immunogenic anigens (Pati and 
Srivastava, 1996) in P. multocida which induce protection in animals against the disease and 
to enhance the virulence in infected animals through an antiphagocytic mechanism (Srivastava, 
1998). OMPs of many Gram negative bacteria are well recognized to be considered as potential 
immunogen. In E. coli, the OMPs were first detected to be protective in turkeys against 
colisepticaemia confirmed by Bolin and Jensen, (1987). Later on, OMPs were also 
demonstrated in Psedumonas aeroginosa reported by Sokol and Woods, (1986) and Shigella 
species (Adamus et al., 1980).  
5.4.3. Immune respose of anti-idiotype vaccine in buffaloes versus cattle  
The P. multocida OMPs anti-idiotype vaccine showed also variable results of antibody 
titres in both groups B3 and C3 (Fig.3 and 4). The antibody titre primarily was higher in 
buffaloes than cattle at 10 days post vaccination. The titre was remained higher in buffaloes 
with GMT 90.5 and in cattle was 84.4 at 40 days post vaccination. Similarly the titres were 
observed to increase with higher values in buffaloes than cattle alongwith peak levels at 100 
days post vaccination (Table 27). The antibody titre was started to decline at 130 days post 
vaccination with higher titres in cattle than buffaloes. The GMT antibodies continued to decline 
in both groups of the animals at 160 days post vaccination and provided 100% challenge 
protection (Table 26). Then declining trend was observed continously till 250 days post 
vaccination showing higher GMT antibody titres in buffaloes than cattle. The antibody titre 
was found likewise at 280 days post vaccination in both groups. However, the antibody titre 
continued to decrease till 370 days post vaccination.  
There is a wide range of applications for anti-idiotypic antibodies, ranging from 
vaccination agaisnt bacterial, fungal, parasitic, and viral infection. (Shoenfeld et al., 1994 and 
Chatterjee et al., 2000)  
Antibodies are powerful molecules and have widespread use in many areas of 
diagnostics biotechnology, medical research, and therapeutics. (Glennie and Johnson, 2000 and 
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Reichert, 2001). Anti-Id antibodies recognizing antigenic determinants can mimic the antigen, 
there is also the possibility that they carry an “internal image” of the original antigen (Williams 
et al., 1990, Pan et al., 1995 and Goldbaum et al., 1997).  
The antibody molecule that is produced as a response to the original antigen becomes itself an 
antigen and elicits the synthesis of a secondary antibody called an “anti-idiotypic antibody.” 
Even today vaccination is regarded as the most cost-effective medical strategy in the prevention 
of infections and has been successfully used for the eradication of important infectious diseases 
such as tetanus, polio, diphtheria and smallpox (Andre, 2003). Conventional vaccines can be 
divided into three groups:purified microbial antigens, attenuated vaccines, inactivated 
vaccines, and. Modernized advances in biotechnology have given insight about various tools 
which can help in the formation of novel vaccines such as recombinant proteins, recombinant 
microorganisms and synthetic peptides (Plotkin, 2002 and Ellis, 1999). These types of vaccine 
have advantages and disadvantages, and one of the potential replacements is the use of anti-
idiotypic antibodies, especially where the use of liveattenuated vaccine is not recommended 
(Thanavala, 1989 and Delves et al., 1997).  
In order to improve the immunogenicity of the conventional vaccines, P. multocida B: 2 OMPs 
anti-idiotype vaccine was prepared and evaluated, and it could be valuable in the control of 
HS. The result of immunogenicity of P. multocida OMPs anti-idiotype vaccine indicated an 
upsurge in the IHA antibody in terms of rapidity and sustainably higher immune response up 
to 100 days in calves. In HS endemic areas, vaccination is considered to be an effective means 
of controlling the disease prophylactically. Simple aluminium hydroxide gel adsorbed and oil 
based vaccines are available on the market and these bacterins necessitated the farmers to 
vaccinate their animals quarterly. In recent years, B: 2 strains of P. multocida have been 
reported to possess membrane proteins (Muniret al., 1987 which prove to be protective in 
rabbits (Shoung et al., 1991).  
 Anti-Id antibodies have found wide range of application in the treatment of viral, bacterial, 
fungal, and parasitic infections (Kanget al., 1992, Sacks et al., 1985 and Westernik et al., 
1988).  
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Table.28. The Cost of production of  the Experimental vaccines.  
Category  Items                                 Types of vaccines  
Plain Bacterin  OMps Subnit  Anti-idiotype  
(A)     
1.Media  and  
Chemicals  
  
2.Glassware  
  
3.Consumable Cost  
Blood Agar,  
Brain Heart  
Infusion Broth,   
PBS,  Formalin, 
Aluminium 
hydroxide gel 
etc  
Rs.8000  
Casein Sucrose 
yeast Agar, 
Sodium lauryl  
Sarcocinate,  
HEPES,adjuvant  
etc  
  
Rs.12000  
Casein Sucrose  
Yeast Agar, Brain   
Brain Heart   
Infusion Broth, 
Pepsin, Sodium 
aetate, adjuvant etc  
Rs.15000  
  
(B)   1.Lab Animals  
  
2.Cost  
Rabbits  
  
Rs.1000  
Rabbit  
  
Rs.1000  
1.Rabbits  
2.Sheep   
Rs.50000  
(C)     
1.Lab Instruments  
  
  
  
  
  
2.Capital Cost  
Microscope,  
Incubator,  
Autoclave,  
  
  
  
  
Rs.8000  
Microscope,  
Incubator,  
Autoclave,  Ultra  
Centrifugation,    
Machine  
  
  
Rs.8000  
Microscope  
Incubator  
Autoclave  
Refrigerator  
Centrifugation   
Machine  
Dialysis 
apparatus  
Rs.12000  
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(D)     
   Utilities  
  
  
  
Cost /Charges  
  
1.Electricity  
2.Gas  
3.Water   
  
Rs.3000  
  
1.Electricity  
2.Gas  
3.Water    
  
Rs.4000  
  
1.Electricity  
2.Gas  
3.Water   
4.Labs Services   
Rs.6000  
                         Total Cost  Rs.20000  Rs.25000  Rs.83000  
                         Doses Prepared  100  100  100  
                         Cost Per Dose  Rs.200  Rs.250  RS.830  
CONCLUSION  
Anti-idiotype vaccine against P. multocida B: 2 OMPs induced better immunogenicity as 
compared to the bacterin and sub-unit OMPs vaccines.A peak IHA geomean antibody titre was 
attained with 147 and 137 at 100th day post vaccination in buffaloes and cattle respectively. 
Anti-idiotype vaccine against P. multocida B: 2 OMPs gave 100% protection while other 
vaccines could not provide more than 67% protection                           
FUTURE PERSPECTIVES  
Since the eradication of HS is not a realistic option for the time being, even prophylact ic 
vaccination. A sound HS control programme may be designed at national level provided that 
the development of efficacious vaccines to meet international standards. Therefore, focus 
should be placed on supporting the applied research and a well recoginsed programme of work 
for action to be taken in the continent, as well as standardization of biological products and 
procedures up to the extent possible. Eventually encourage and support research and 
development of technology for the production of safe potent  efficacious  vaccines as well as 
the anti-idiotype vaccines is necessitated The proposed formulation that offers the majority of 
the ideal criteria of a vaccine is anti-idiotype against P. multocida heterologus strains may also 
be applied. The present status of anti-idiotype P. multocida vaccine may be considered 
realistically in zoonotic perspectives. Meanwhile there is a need to develop anti-idiotype 
vaccine against other highly infectious diseases of animals. Efforts should be made  to 
minimize the cost of vaccine production in future.  
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CHAPTER VI  
SUMMARY  
The present research work was carried out with a view to prevalence of HS (July to August 
2011) in relation to agro-climatic zones of Chiniot and Faisalabad with isolation P. multocida 
from the field outbreaks. The isolates were identified by cultural, morphological and 
biochemical characters. A total of 249 samples comprising of blood and nasal swabs each 202 
and 47 organ samples ( heart, liver, lung) from the suspected cases of HS from cattle and 
buffaloes were collected and processed for preparation of smears as well as for inoculation on 
BA, CSY agar for demonstration of bipolar organisms and isolation of P.multocida, 
respectively. The bipolar organisms could be demonstrated in smears of blood samples from 
blood of buffaloes only and the same blood samples yielded the recovery of P. multocida. On 
BA the colonies of isolates were non-haemolytic, round, grayish, smooth or mucoid and no 
growth was observed on MCA. The isolates were Gram negative coccobacilli rods. All the 
isolates were found to be positive for, catalase, indole `production,  hydrogen sulphide 
production, nitrate reduction and fermentation of  lactose and dulcitol were negative. Out of 
eight, six isolates were identified with 99.9%  by API 20 E which is excellent identification. In 
vitro antibiotic sensitivity of the isolates was performed against most commonly used ten 
antibiotics. Among the eight isolates studied all of them (100%) were sensitive to Florfenico l 
and Cephalexin, while 50% were found sensitive to Tetracycline, Ampicillin and 
Nitrofurantoin. All the isolates (100%) were found resistant to Penicillin-G and 75 % to  
Ceftiofur, Norfloxacin and Ciprofloxacin.The Pasteurella multocida-PCR based detection was 
also conducted for confirmation of P. multocida. The isolates of P. multocida along with 
standard strain and E.coli (negative control) were subjected to PCR using the primer pairs 
92  
  
KTT72 and KTSP61. PCR product was electrophoresed on two per cent agarose gel. The 
isolates including standard strain showed an amplified product of approximately 560 bp and 
760 bp siz eof serotype B: 2 while E.coli (negative control) could not show amplification by 
these primers. The objectives of the present study were the characterization of the P. multocida 
isolates along with purification of their outer membrane proteins. For the characterization of 
the isolates on the basis of the presence of outer membrane proteins, the cultures were grown 
in Brain heart infusion broth and then OMPs was extracted by using sarkosyl method. In this 
study, OMPs of six P. multocida field isolates and standared strain PM 2004 were subjected to 
SDS-PAGE. The capsular type B: 2 protein profiles electrophretically showed the presence of 
4 protein fractions which were ranged from 32 to 90 KDa. Based on band intensity, three 
common polypeptides with MW of approx 90, 70 and 32 KDa and one common polypeptide 
light band 44 KDa were the main OMPs. Two types of experimental vaccines were prepared 
including P. multocida OMPs subunit vaccine and OMPs anti-idiotype vaccine where as 
bacterin HS (alum precipitated) was used as control vaccine. OMPs sub-unit vaccine prepared 
as the purified OMPs (10% ) were mixed with equal volume (v/v) of Montanide  ISA70, final 
concentration of OMPs as active protein concentration was 133.3 µg/ml. The rabbits were 
hyperimmunized with OMPs subunit vaccine to obtain idiotypes. Purified Fab from the rabbits 
were inoculated in to the sheep and OMPs anti-idiotype vaccine was prepared. Quality 
standards test of the experimemtal vaccines were checked prior to trial. The experimenta l 
vaccines were trialed in various groups of cattle and buffaloes and immune response was 
detected by IHA test on monthly basis and continued up to 370 days post vaccination. P. 
multocida OMPs anti-idiotype showed peak IHA antibodies at 100 th days post vaccination in 
both groups of cattle and buffaloes fallowed by OMPs sub-unit vaccine and simple bacterin. 
Three calves from each vaccinated groups were challenged against homologus strain of P. 
multocida. Anti-idiotype remained 100% prorective. Cost of  production of the anti-idiotype 
vaccine was estimated and compared (Table 28)  with the preparation  of P. multocida OMPs  
subunit and  plain bacterin,  indicated that  the cost of production of anti-idiotype vaccine was 
Rs.830/dose.  
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`                                          APPENDIX - I  
  
Blood Agar   
Blood agar base (Dehydrated, HiMedia)  
Ingredients Grams/liter  
Beef heart, infusion form 500.00  
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Tryptose 10.00  
Sodium chloride 5.00  
Agar 15.00  
Final pH (at 25°C) 7.3 + 0.2  
Suspended 40 gm of dehydrated blood agar base in 1 litredistilled water and sterilized by 
autoclaving at 15 psi pressure, 121°C temperature for 20 minutes. The molten medium was 
cooled to about 50°C temperature and aseptically 5% v/v sterile defibrinated sheep blood was 
added. The above medium was mixed well and poured into sterile petri plates.  
Brain Heart Infusion Broth (BHI broth)  
(Dehydrated, HiMedia)  
Ingredients Grams/liter  
Peptic digest of animal tissues 10.00  
Calf brains, infusion (solids) Yeast extract 12.50  
Beef heart Infusion (solids) 5.00  
Dextrose 2.00  
Sodium chloride 5.00 
Disodium phosphate 2.50  
pH (at 25°C) 7.4 + 0.2  
Suspended 37 gm in 1000 ml distilled water, distributed in test tube and sterilized by 
autoclaving at 15 psi pressure, 121°C for20 minutes.  
Casein Sucrose Yeast Agar (CSY) Ingredients Grams/liter  
Acid hydrolysate of casein 3.0   
Sucrose 3.0  
Yeast extract 5.0  
Sodium chloride anhydrous 5.0  
Dipotassium hydrogen orthophospate anhydrous 2.0 
Agar 15.0 pH 7.4  
  
                                             APPENDIX-II  
Indole test a) Kovac’s reagents  
Paradimethylaminobenzaldehyde 50 gm  
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Pure amyl or Isoamyl alcohol 75 ml  
Concentrated pure hydrochloric acid 25 ml  
The aldehyde was dissolved in the alcohol by gentle warming in waterbath, cooled and then 
hydrochloric acid was added. Protected from light and was stored at 4°C temperature. b) 
Tryptone water Tryptone 10 gm  
Sodium chloride 5 gm  
Distilled water 1000 ml  
The ingredients were dissolved in distilled water by gentle warming and then sterilized at 15 
psi pressure, 121°C temperature for 20 minutes.  
Nitrate reduction test Test medium  
Peptone 10.00 gm  
Sodium chloride 5.00 gm  
Distilled water 1000.00 ml  
Adjusted pH to 7.4 then added  
Potassium nitrate 1.00 gm  
The above medium was sterilized by autoclaving at 10 psi Pressure, 
115°C temperature for 30 minutes.  
Test reagents  
a) Sulfanilic acid: 8.0 gm of sulphanilic acid was dissolved in 1000 
ml of 5M acetic acid.  
b) Alpha naphthylamine: 5 gm of alpha naphthylamine was dissolved 
in 1000 ml of 5M acetic acid. Sugar fermentation test a) Peptone 
water Peptone 10.00 gm  
Sodium chloride 5.00 gm 
Distilled water 1000.00 ml  
pH (at 25°C) 7.5  
b) Andrade’s indicator  
0.5 gm acid fuschin was dissolved in 100 ml distilled water. Then 16ml of 1M NaOH was 
added. A 10 ml of indicator was used for each litre of medium.1 gm of appropriate sugar was 
dissolved in 100 ml basal medium, distributed in test tube and sterilized at 10 psi pressure, 
115 °C temperature for 30 minutes.  
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Gram’s stain 1 Ammonium oxalate crystal violet  
Solution 1: Crystal violet 2.0 gm  
Ethyl alcohol (95 per cent) 20.0 ml  
Solution 2: Ammonium oxalate 0.8 gm  
Distilled water 80.0 ml  
Solution 1 and 2 was mixed well and then filtered.  
2 Gram’s iodine solution Iodine 
1.0 gm  
Potassium iodide 2.0 gm  
The ingredients were dissolved in distilled water to make total volume 300 ml and then filtered.  
3 Acetone or Ethyl alcohols (decolorizer)  
4 Safranin (counter stain) 
Safranin-O (2.5 per cent solution) in 
95 per cent alcohol 10 ml  
Distilled water 100 ml  
Leishman’s stain of Leishman powder in 100 ml methyle alcohol  
                                                   
                                           APPENDIX- III  
Thioglycollate Broth  
Final pH 7.1 ± 0.2 at 25ºC                                                                                                     
Preparation                                                                                                                                  
Suspended 28.5 grams of the medium in one litre of distilled water. Then mix well and dissolve 
by heating with frequent agitation. Boil for one minute until complete dissolution. Dispense 
into appropriate containers and sterilize in autoclave at121°C for 15 minutes.  
Eliminate any dissolved oxygen before use by heating in boiling water or in a water bath.  
 Casein Peptone      15 g   
 Sodium chloride      2.5 g  
 Yeast Extract       5 g  
 Sodium Thioglycollate    0.5 g  
Dextrose        5g                                                                                                               
L-Cystine        0.5 g                                           
111  
  
The prepared medium should be stored at 2-8°C. The color is amber, slightly opalescent.  
  
  
  
